date generated: 2022-03-15
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik -0.3304181
## 0610009E02Rik 0.7596333
## 0610009L18Rik -1.2521412
## 0610010K14Rik 0.4193627
## 0610012G03Rik 1.4462155
## 0610030E20Rik -0.2426628
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17078 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8370 |
num_profile_genes_not_in_sets | 8708 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 425 |
num_genesets_included | 1179 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.45e-06 | 0.628 | 5.72e-04 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 2.28e-04 | 0.590 | 5.96e-03 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 1.23e-05 | 0.579 | 7.25e-04 |
CGMP EFFECTS | 15 | 1.52e-04 | -0.565 | 4.73e-03 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.33e-03 | -0.559 | 2.12e-02 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 5.99e-05 | -0.518 | 2.21e-03 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.23e-05 | 0.511 | 1.10e-03 |
P75NTR REGULATES AXONOGENESIS | 10 | 6.88e-03 | -0.494 | 6.59e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.10e-03 | -0.476 | 8.01e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 3.37e-03 | 0.470 | 4.02e-02 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.08e-02 | -0.444 | 9.12e-02 |
GAP JUNCTION ASSEMBLY | 21 | 5.68e-04 | 0.434 | 1.12e-02 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 4.02e-07 | 0.414 | 7.94e-05 |
GLYCOGEN STORAGE DISEASES | 12 | 1.42e-02 | 0.409 | 1.07e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 1.43e-05 | -0.402 | 8.01e-04 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 4.16e-05 | 0.395 | 1.82e-03 |
AGGREPHAGY | 35 | 5.81e-05 | 0.393 | 2.21e-03 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 5.45e-08 | 0.387 | 2.14e-05 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 1.63e-02 | 0.385 | 1.16e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 3.53e-02 | -0.384 | 1.96e-01 |
INTRAFLAGELLAR TRANSPORT | 51 | 2.07e-06 | 0.384 | 2.44e-04 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 7.27e-04 | 0.383 | 1.32e-02 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.81e-02 | -0.382 | 1.65e-01 |
XENOBIOTICS | 10 | 3.78e-02 | -0.379 | 2.07e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 2.96e-02 | -0.379 | 1.72e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.86e-02 | -0.378 | 2.09e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 3.95e-02 | -0.376 | 2.12e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.96e-03 | -0.373 | 2.85e-02 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 4.22e-02 | -0.371 | 2.21e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 1.23e-04 | -0.370 | 3.93e-03 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 2.04e-02 | 0.358 | 1.34e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 5.03e-02 | -0.357 | 2.35e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 1.73e-02 | -0.355 | 1.18e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 3.02e-03 | 0.350 | 3.79e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 5.55e-02 | -0.350 | 2.51e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.02e-02 | 0.347 | 1.75e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 5.86e-02 | -0.345 | 2.63e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 2.17e-02 | -0.342 | 1.38e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 8.81e-03 | 0.338 | 7.86e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.44e-02 | -0.338 | 2.79e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.41e-02 | 0.334 | 1.07e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 6.93e-03 | 0.333 | 6.59e-02 |
DISEASES OF CARBOHYDRATE METABOLISM | 28 | 2.48e-03 | 0.330 | 3.22e-02 |
KERATAN SULFATE DEGRADATION | 12 | 5.18e-02 | 0.324 | 2.39e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 4.72e-05 | 0.323 | 1.99e-03 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.60e-04 | 0.322 | 4.73e-03 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 6.40e-03 | 0.322 | 6.39e-02 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 7.93e-02 | -0.320 | 3.15e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 5.77e-05 | 0.319 | 2.21e-03 |
RA BIOSYNTHESIS PATHWAY | 12 | 5.55e-02 | 0.319 | 2.51e-01 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.45e-06 | 0.628000 | 5.72e-04 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 2.28e-04 | 0.590000 | 5.96e-03 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 1.23e-05 | 0.579000 | 7.25e-04 |
CGMP EFFECTS | 15 | 1.52e-04 | -0.565000 | 4.73e-03 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.33e-03 | -0.559000 | 2.12e-02 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 5.99e-05 | -0.518000 | 2.21e-03 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.23e-05 | 0.511000 | 1.10e-03 |
P75NTR REGULATES AXONOGENESIS | 10 | 6.88e-03 | -0.494000 | 6.59e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.10e-03 | -0.476000 | 8.01e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 3.37e-03 | 0.470000 | 4.02e-02 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.08e-02 | -0.444000 | 9.12e-02 |
GAP JUNCTION ASSEMBLY | 21 | 5.68e-04 | 0.434000 | 1.12e-02 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 4.02e-07 | 0.414000 | 7.94e-05 |
GLYCOGEN STORAGE DISEASES | 12 | 1.42e-02 | 0.409000 | 1.07e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 1.43e-05 | -0.402000 | 8.01e-04 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 4.16e-05 | 0.395000 | 1.82e-03 |
AGGREPHAGY | 35 | 5.81e-05 | 0.393000 | 2.21e-03 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 5.45e-08 | 0.387000 | 2.14e-05 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 1.63e-02 | 0.385000 | 1.16e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 3.53e-02 | -0.384000 | 1.96e-01 |
INTRAFLAGELLAR TRANSPORT | 51 | 2.07e-06 | 0.384000 | 2.44e-04 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 7.27e-04 | 0.383000 | 1.32e-02 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.81e-02 | -0.382000 | 1.65e-01 |
XENOBIOTICS | 10 | 3.78e-02 | -0.379000 | 2.07e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 2.96e-02 | -0.379000 | 1.72e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.86e-02 | -0.378000 | 2.09e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 3.95e-02 | -0.376000 | 2.12e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.96e-03 | -0.373000 | 2.85e-02 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 4.22e-02 | -0.371000 | 2.21e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 1.23e-04 | -0.370000 | 3.93e-03 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 2.04e-02 | 0.358000 | 1.34e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 5.03e-02 | -0.357000 | 2.35e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 1.73e-02 | -0.355000 | 1.18e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 3.02e-03 | 0.350000 | 3.79e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 5.55e-02 | -0.350000 | 2.51e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.02e-02 | 0.347000 | 1.75e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 5.86e-02 | -0.345000 | 2.63e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 2.17e-02 | -0.342000 | 1.38e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 8.81e-03 | 0.338000 | 7.86e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.44e-02 | -0.338000 | 2.79e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.41e-02 | 0.334000 | 1.07e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 6.93e-03 | 0.333000 | 6.59e-02 |
DISEASES OF CARBOHYDRATE METABOLISM | 28 | 2.48e-03 | 0.330000 | 3.22e-02 |
KERATAN SULFATE DEGRADATION | 12 | 5.18e-02 | 0.324000 | 2.39e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 4.72e-05 | 0.323000 | 1.99e-03 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.60e-04 | 0.322000 | 4.73e-03 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 6.40e-03 | 0.322000 | 6.39e-02 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 7.93e-02 | -0.320000 | 3.15e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 5.77e-05 | 0.319000 | 2.21e-03 |
RA BIOSYNTHESIS PATHWAY | 12 | 5.55e-02 | 0.319000 | 2.51e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 2.56e-03 | 0.318000 | 3.29e-02 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 4.82e-02 | -0.316000 | 2.29e-01 |
METABOLISM OF STEROID HORMONES | 22 | 1.07e-02 | 0.314000 | 9.12e-02 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 2.24e-05 | 0.311000 | 1.10e-03 |
PHASE 0 RAPID DEPOLARISATION | 30 | 3.21e-03 | -0.311000 | 3.98e-02 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 4.43e-02 | -0.310000 | 2.22e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 2.36e-07 | 0.310000 | 6.94e-05 |
STABILIZATION OF P53 | 54 | 8.10e-05 | 0.310000 | 2.65e-03 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 1.44e-02 | -0.309000 | 1.07e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 9.17e-02 | -0.308000 | 3.49e-01 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 3.40e-05 | 0.307000 | 1.59e-03 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.84e-02 | 0.305000 | 1.23e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 2.54e-02 | -0.304000 | 1.54e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.16e-02 | 0.304000 | 9.65e-02 |
TRNA AMINOACYLATION | 42 | 7.30e-04 | 0.301000 | 1.32e-02 |
PREGNENOLONE BIOSYNTHESIS | 12 | 7.14e-02 | 0.301000 | 2.99e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 5.17e-02 | -0.300000 | 2.39e-01 |
DEGRADATION OF AXIN | 53 | 1.62e-04 | 0.300000 | 4.73e-03 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 3.51e-04 | 0.298000 | 8.12e-03 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.59e-06 | 0.298000 | 2.25e-04 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 7.99e-05 | 0.297000 | 2.65e-03 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 15 | 4.72e-02 | 0.296000 | 2.29e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 2.58e-02 | -0.295000 | 1.55e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 9.15e-02 | -0.294000 | 3.49e-01 |
HEME SIGNALING | 45 | 6.84e-04 | -0.293000 | 1.28e-02 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 9.89e-03 | -0.292000 | 8.64e-02 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 2.08e-02 | -0.291000 | 1.35e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 2.11e-02 | -0.291000 | 1.35e-01 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 2.46e-04 | 0.288000 | 6.18e-03 |
HS GAG DEGRADATION | 21 | 2.23e-02 | 0.288000 | 1.41e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 1.53e-02 | -0.286000 | 1.10e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 1.01e-01 | -0.286000 | 3.69e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 1.53e-02 | 0.286000 | 1.10e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 1.05e-01 | 0.283000 | 3.77e-01 |
LONG TERM POTENTIATION | 23 | 1.98e-02 | -0.281000 | 1.32e-01 |
PARASITE INFECTION | 55 | 3.25e-04 | -0.280000 | 7.73e-03 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 5.47e-03 | 0.279000 | 5.69e-02 |
JOSEPHIN DOMAIN DUBS | 11 | 1.10e-01 | 0.278000 | 3.85e-01 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 1.10e-01 | -0.278000 | 3.85e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 4.73e-02 | -0.278000 | 2.29e-01 |
GLUCONEOGENESIS | 27 | 1.26e-02 | 0.278000 | 1.01e-01 |
DEGRADATION OF DVL | 55 | 3.80e-04 | 0.277000 | 8.60e-03 |
ERBB2 REGULATES CELL MOTILITY | 14 | 7.28e-02 | -0.277000 | 3.03e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 5.52e-02 | -0.277000 | 2.51e-01 |
DSCAM INTERACTIONS | 10 | 1.31e-01 | -0.276000 | 4.23e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 6.46e-02 | 0.276000 | 2.79e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 1.14e-01 | -0.275000 | 3.95e-01 |
OLFACTORY SIGNALING PATHWAY | 25 | 1.80e-02 | -0.273000 | 1.21e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 6.73e-02 | -0.273000 | 2.86e-01 |
ZINC TRANSPORTERS | 16 | 5.98e-02 | -0.272000 | 2.67e-01 |
SIGNALING BY LEPTIN | 10 | 1.38e-01 | 0.271000 | 4.35e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 4.13e-02 | -0.270000 | 2.17e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 3.28e-04 | -0.270000 | 7.73e-03 |
PCP CE PATHWAY | 89 | 1.05e-05 | 0.270000 | 7.15e-04 |
HEDGEHOG OFF STATE | 106 | 1.72e-06 | 0.269000 | 2.25e-04 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 10 | 1.42e-01 | -0.268000 | 4.37e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 8.31e-02 | -0.268000 | 3.27e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 3.41e-02 | 0.267000 | 1.93e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 3.99e-04 | 0.267000 | 8.88e-03 |
SIGNALING BY ERBB2 IN CANCER | 25 | 2.11e-02 | -0.267000 | 1.35e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 5.07e-04 | 0.266000 | 1.07e-02 |
METABOLISM OF FAT SOLUBLE VITAMINS | 35 | 6.79e-03 | 0.264000 | 6.59e-02 |
METAL ION SLC TRANSPORTERS | 25 | 2.26e-02 | -0.263000 | 1.42e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.52e-01 | -0.262000 | 4.47e-01 |
SIGNALING BY BMP | 25 | 2.38e-02 | -0.261000 | 1.46e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 1.65e-04 | 0.261000 | 4.73e-03 |
CA DEPENDENT EVENTS | 36 | 6.87e-03 | -0.260000 | 6.59e-02 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 4.56e-02 | -0.258000 | 2.26e-01 |
TRANSLATION | 286 | 6.58e-14 | 0.258000 | 7.76e-11 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 4.60e-02 | -0.258000 | 2.26e-01 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 7.48e-02 | -0.257000 | 3.08e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 40 | 4.90e-03 | 0.257000 | 5.35e-02 |
AMINE LIGAND BINDING RECEPTORS | 29 | 1.69e-02 | -0.256000 | 1.16e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 2.38e-02 | 0.256000 | 1.46e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 4.49e-04 | 0.256000 | 9.76e-03 |
METABOLISM OF POLYAMINES | 57 | 8.64e-04 | 0.255000 | 1.52e-02 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 1.62e-01 | -0.255000 | 4.64e-01 |
TIE2 SIGNALING | 17 | 6.92e-02 | -0.255000 | 2.92e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 1.12e-01 | 0.255000 | 3.91e-01 |
HSF1 ACTIVATION | 25 | 2.87e-02 | 0.253000 | 1.67e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 5.25e-04 | 0.253000 | 1.09e-02 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 6.39e-02 | 0.252000 | 2.78e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 1.66e-03 | -0.252000 | 2.50e-02 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 1.70e-02 | -0.252000 | 1.16e-01 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 7.76e-06 | 0.251000 | 5.72e-04 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 1.18e-01 | -0.251000 | 3.98e-01 |
PEXOPHAGY | 11 | 1.51e-01 | 0.250000 | 4.46e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 1.35e-01 | -0.249000 | 4.28e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 86 | 7.18e-05 | 0.248000 | 2.49e-03 |
DAG AND IP3 SIGNALING | 40 | 6.93e-03 | -0.247000 | 6.59e-02 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 1.24e-01 | -0.247000 | 4.07e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 1.11e-03 | 0.245000 | 1.82e-02 |
HSF1 DEPENDENT TRANSACTIVATION | 33 | 1.48e-02 | 0.245000 | 1.09e-01 |
PYRIMIDINE SALVAGE | 10 | 1.81e-01 | 0.244000 | 4.86e-01 |
ATTENUATION PHASE | 23 | 4.40e-02 | 0.243000 | 2.22e-01 |
POTASSIUM CHANNELS | 91 | 7.07e-05 | -0.241000 | 2.49e-03 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 4.11e-02 | 0.241000 | 2.17e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 7.71e-02 | -0.241000 | 3.11e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 1.34e-01 | -0.240000 | 4.28e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 1.51e-01 | 0.239000 | 4.46e-01 |
SELENOAMINO ACID METABOLISM | 109 | 1.76e-05 | 0.238000 | 9.42e-04 |
SIGNALING BY HIPPO | 20 | 6.54e-02 | -0.238000 | 2.81e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 9.60e-04 | 0.237000 | 1.62e-02 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 1.55e-01 | -0.237000 | 4.51e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 2.42e-04 | 0.236000 | 6.18e-03 |
CROSSLINKING OF COLLAGEN FIBRILS | 16 | 1.05e-01 | 0.234000 | 3.77e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 1.60e-01 | 0.234000 | 4.59e-01 |
INTERLEUKIN 10 SIGNALING | 19 | 7.80e-02 | -0.234000 | 3.12e-01 |
GAB1 SIGNALOSOME | 14 | 1.30e-01 | -0.234000 | 4.23e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 1.29e-02 | 0.233000 | 1.02e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 1.14e-03 | 0.232000 | 1.84e-02 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 7.85e-03 | 0.232000 | 7.12e-02 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 1.23e-01 | -0.230000 | 4.05e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 28 | 3.52e-02 | -0.230000 | 1.96e-01 |
RMTS METHYLATE HISTONE ARGININES | 45 | 7.65e-03 | 0.230000 | 7.04e-02 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 7.52e-02 | -0.230000 | 3.08e-01 |
ACTIVATION OF RAC1 | 13 | 1.53e-01 | -0.229000 | 4.47e-01 |
DEADENYLATION OF MRNA | 25 | 4.78e-02 | -0.229000 | 2.29e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 1.67e-02 | -0.227000 | 1.16e-01 |
DARPP 32 EVENTS | 23 | 6.34e-02 | -0.224000 | 2.77e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 8.36e-02 | -0.224000 | 3.27e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 2.21e-01 | -0.223000 | 5.33e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 2.37e-03 | 0.223000 | 3.16e-02 |
CARDIAC CONDUCTION | 109 | 6.00e-05 | -0.223000 | 2.21e-03 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.02e-03 | -0.222000 | 1.70e-02 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 4.24e-02 | -0.222000 | 2.21e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 6.68e-04 | 0.222000 | 1.27e-02 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 1.67e-01 | -0.221000 | 4.66e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 1.05e-01 | 0.221000 | 3.77e-01 |
HDMS DEMETHYLATE HISTONES | 28 | 4.37e-02 | -0.220000 | 2.22e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 4.38e-02 | -0.220000 | 2.22e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 49 | 7.71e-03 | -0.220000 | 7.04e-02 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.07e-01 | -0.220000 | 5.15e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 2.17e-04 | 0.220000 | 5.82e-03 |
INTERFERON GAMMA SIGNALING | 77 | 8.65e-04 | -0.220000 | 1.52e-02 |
INSULIN PROCESSING | 24 | 6.32e-02 | -0.219000 | 2.77e-01 |
RECYCLING PATHWAY OF L1 | 40 | 1.67e-02 | 0.219000 | 1.16e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.43e-01 | -0.219000 | 4.37e-01 |
MISMATCH REPAIR | 14 | 1.58e-01 | 0.218000 | 4.54e-01 |
NUCLEOTIDE SALVAGE | 21 | 8.39e-02 | 0.218000 | 3.27e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 1.10e-01 | 0.218000 | 3.85e-01 |
CA2 PATHWAY | 58 | 4.20e-03 | -0.217000 | 4.72e-02 |
LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 3.35e-02 | 0.217000 | 1.92e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 1.22e-02 | -0.216000 | 9.95e-02 |
SELECTIVE AUTOPHAGY | 72 | 1.59e-03 | 0.215000 | 2.44e-02 |
RHOJ GTPASE CYCLE | 54 | 6.25e-03 | -0.215000 | 6.30e-02 |
SIGNALING BY HEDGEHOG | 141 | 1.09e-05 | 0.215000 | 7.15e-04 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 1.50e-01 | 0.214000 | 4.46e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 2.41e-01 | 0.214000 | 5.53e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 9.74e-02 | -0.214000 | 3.62e-01 |
RHOQ GTPASE CYCLE | 58 | 4.84e-03 | -0.214000 | 5.33e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 160 | 3.20e-06 | 0.214000 | 3.14e-04 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 1.70e-02 | -0.210000 | 1.16e-01 |
TIGHT JUNCTION INTERACTIONS | 17 | 1.34e-01 | -0.210000 | 4.28e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 4.65e-02 | -0.210000 | 2.27e-01 |
ACTIVATION OF SMO | 16 | 1.46e-01 | 0.210000 | 4.42e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 5.52e-04 | 0.210000 | 1.10e-02 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 1.15e-01 | -0.209000 | 3.95e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 9.74e-02 | 0.209000 | 3.62e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 2.53e-01 | 0.209000 | 5.62e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 24 | 7.66e-02 | 0.209000 | 3.10e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 1.49e-01 | -0.209000 | 4.46e-01 |
REGULATION OF RAS BY GAPS | 66 | 3.44e-03 | 0.208000 | 4.06e-02 |
CELLULAR RESPONSE TO HYPOXIA | 72 | 2.37e-03 | 0.207000 | 3.16e-02 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 2.19e-01 | 0.205000 | 5.31e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 2.45e-03 | -0.205000 | 3.21e-02 |
INTERFERON SIGNALING | 165 | 5.69e-06 | -0.205000 | 4.79e-04 |
CELL CELL JUNCTION ORGANIZATION | 49 | 1.32e-02 | -0.205000 | 1.03e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 4.51e-02 | 0.205000 | 2.24e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 2.64e-01 | -0.204000 | 5.72e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 8.34e-02 | -0.204000 | 3.27e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 1.86e-01 | -0.204000 | 4.90e-01 |
ABC TRANSPORTER DISORDERS | 70 | 3.24e-03 | 0.204000 | 3.98e-02 |
PLASMA LIPOPROTEIN CLEARANCE | 28 | 6.24e-02 | 0.203000 | 2.77e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 2.24e-01 | 0.203000 | 5.37e-01 |
SIGNALING BY FGFR1 IN DISEASE | 33 | 4.42e-02 | -0.202000 | 2.22e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 5.16e-02 | -0.202000 | 2.39e-01 |
RRNA PROCESSING | 194 | 1.27e-06 | 0.202000 | 2.14e-04 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 1.98e-04 | 0.202000 | 5.43e-03 |
MRNA SPLICING MINOR PATHWAY | 52 | 1.21e-02 | 0.201000 | 9.95e-02 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 6.27e-02 | 0.200000 | 2.77e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 7.83e-02 | -0.200000 | 3.12e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 65 | 5.49e-03 | 0.199000 | 5.69e-02 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 2.15e-01 | -0.199000 | 5.26e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 2.55e-01 | 0.198000 | 5.62e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 1.85e-01 | 0.198000 | 4.89e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 4.96e-02 | -0.197000 | 2.32e-01 |
RAP1 SIGNALLING | 15 | 1.86e-01 | -0.197000 | 4.89e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 2.82e-01 | -0.197000 | 5.91e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 7.74e-02 | 0.196000 | 3.11e-01 |
HEDGEHOG ON STATE | 82 | 2.17e-03 | 0.196000 | 3.04e-02 |
KINESINS | 47 | 2.04e-02 | 0.196000 | 1.34e-01 |
HS GAG BIOSYNTHESIS | 29 | 6.90e-02 | 0.195000 | 2.92e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 4.93e-02 | 0.195000 | 2.32e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 1.32e-01 | 0.195000 | 4.27e-01 |
NONSENSE MEDIATED DECAY NMD | 109 | 4.55e-04 | 0.194000 | 9.76e-03 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 5.72e-02 | -0.194000 | 2.57e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 2.44e-01 | 0.194000 | 5.56e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 1.98e-03 | 0.193000 | 2.85e-02 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 7.74e-02 | 0.193000 | 3.11e-01 |
SULFUR AMINO ACID METABOLISM | 22 | 1.18e-01 | 0.192000 | 3.98e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 2.30e-01 | -0.192000 | 5.43e-01 |
DISEASES OF METABOLISM | 199 | 3.19e-06 | 0.192000 | 3.14e-04 |
GABA RECEPTOR ACTIVATION | 54 | 1.50e-02 | -0.191000 | 1.09e-01 |
ION HOMEOSTASIS | 49 | 2.05e-02 | -0.191000 | 1.34e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 7.47e-02 | -0.191000 | 3.08e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 9.16e-02 | -0.191000 | 3.49e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 1.53e-02 | -0.191000 | 1.10e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 1.24e-02 | -0.190000 | 1.01e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 1.42e-01 | -0.190000 | 4.37e-01 |
RAB GERANYLGERANYLATION | 57 | 1.34e-02 | -0.189000 | 1.03e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.91e-01 | -0.189000 | 4.95e-01 |
COMPLEX I BIOGENESIS | 56 | 1.45e-02 | 0.189000 | 1.08e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 2.89e-03 | 0.188000 | 3.66e-02 |
INTERFERON ALPHA BETA SIGNALING | 56 | 1.49e-02 | -0.188000 | 1.09e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 2.41e-01 | -0.188000 | 5.53e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.57e-01 | -0.188000 | 4.54e-01 |
COLLAGEN FORMATION | 79 | 4.00e-03 | 0.187000 | 4.62e-02 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 2.42e-01 | 0.187000 | 5.54e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 2.82e-01 | 0.187000 | 5.91e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 2.83e-01 | 0.187000 | 5.91e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 7.64e-02 | 0.187000 | 3.10e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 4.10e-02 | -0.187000 | 2.17e-01 |
MYOGENESIS | 25 | 1.06e-01 | -0.187000 | 3.77e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 1.14e-01 | -0.187000 | 3.93e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 2.27e-01 | 0.186000 | 5.39e-01 |
UCH PROTEINASES | 90 | 2.28e-03 | 0.186000 | 3.13e-02 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 1.40e-01 | -0.186000 | 4.37e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 3.62e-03 | -0.186000 | 4.22e-02 |
POLYMERASE SWITCHING | 14 | 2.30e-01 | 0.185000 | 5.43e-01 |
LDL CLEARANCE | 16 | 2.02e-01 | 0.184000 | 5.09e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 3.18e-01 | 0.182000 | 6.21e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 2.22e-01 | -0.182000 | 5.33e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 7.01e-02 | -0.182000 | 2.94e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 15 | 2.23e-01 | 0.182000 | 5.36e-01 |
SIGNALING BY VEGF | 103 | 1.46e-03 | -0.182000 | 2.26e-02 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 4.09e-03 | 0.181000 | 4.64e-02 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 8.70e-02 | 0.181000 | 3.36e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 1.74e-01 | 0.180000 | 4.75e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 317 | 4.08e-08 | 0.180000 | 2.14e-05 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 2.82e-01 | -0.179000 | 5.91e-01 |
PROTEIN FOLDING | 90 | 3.32e-03 | 0.179000 | 4.02e-02 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 2.30e-01 | -0.179000 | 5.43e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 2.58e-02 | -0.179000 | 1.55e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 3.06e-01 | 0.178000 | 6.05e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 10 | 3.29e-01 | -0.178000 | 6.27e-01 |
REGULATION OF IFNA SIGNALING | 12 | 2.86e-01 | 0.178000 | 5.94e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 2.67e-02 | 0.178000 | 1.57e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 16 | 2.19e-01 | -0.178000 | 5.31e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 2.88e-01 | -0.177000 | 5.95e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 21 | 1.60e-01 | 0.177000 | 4.59e-01 |
FCERI MEDIATED NF KB ACTIVATION | 77 | 7.28e-03 | 0.177000 | 6.81e-02 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 1.82e-01 | 0.177000 | 4.86e-01 |
OPIOID SIGNALLING | 87 | 4.53e-03 | -0.176000 | 5.04e-02 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 2.91e-01 | 0.176000 | 5.95e-01 |
SYNTHESIS OF PE | 13 | 2.72e-01 | 0.176000 | 5.84e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 3.36e-01 | -0.176000 | 6.29e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 2.92e-01 | -0.176000 | 5.95e-01 |
THE NLRP3 INFLAMMASOME | 15 | 2.42e-01 | 0.174000 | 5.54e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 1.29e-02 | -0.174000 | 1.02e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.17e-01 | -0.174000 | 3.98e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 12 | 2.96e-01 | 0.174000 | 5.98e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 1.68e-01 | 0.174000 | 4.67e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 2.31e-01 | 0.173000 | 5.43e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 1.43e-01 | -0.173000 | 4.37e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 2.47e-01 | 0.173000 | 5.59e-01 |
ENOS ACTIVATION | 11 | 3.23e-01 | -0.172000 | 6.22e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 2.49e-01 | 0.172000 | 5.59e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 1.95e-01 | -0.172000 | 4.99e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 2.08e-01 | -0.171000 | 5.18e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 9.97e-02 | -0.171000 | 3.68e-01 |
AUTOPHAGY | 139 | 5.48e-04 | 0.170000 | 1.10e-02 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 7.16e-03 | 0.170000 | 6.75e-02 |
IRAK4 DEFICIENCY TLR2 4 | 13 | 2.91e-01 | -0.169000 | 5.95e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 21 | 1.80e-01 | -0.169000 | 4.86e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 1.81e-01 | 0.169000 | 4.86e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 3.33e-01 | 0.169000 | 6.27e-01 |
DAP12 INTERACTIONS | 31 | 1.05e-01 | -0.168000 | 3.77e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 1.54e-01 | 0.168000 | 4.50e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 2.94e-01 | 0.168000 | 5.96e-01 |
CARNITINE METABOLISM | 14 | 2.79e-01 | 0.167000 | 5.90e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 1.49e-01 | 0.167000 | 4.46e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 2.99e-01 | -0.167000 | 6.00e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 1.89e-01 | -0.166000 | 4.91e-01 |
RAC2 GTPASE CYCLE | 87 | 7.66e-03 | -0.165000 | 7.04e-02 |
INTERLEUKIN 1 SIGNALING | 96 | 5.12e-03 | 0.165000 | 5.49e-02 |
CD209 DC SIGN SIGNALING | 18 | 2.25e-01 | -0.165000 | 5.37e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 2.02e-01 | -0.165000 | 5.09e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 30 | 1.18e-01 | 0.165000 | 3.98e-01 |
KERATINIZATION | 30 | 1.18e-01 | 0.165000 | 3.98e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.72e-01 | -0.165000 | 4.72e-01 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 1.82e-01 | 0.165000 | 4.86e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 2.15e-01 | -0.164000 | 5.26e-01 |
CELLULAR RESPONSE TO STARVATION | 146 | 6.31e-04 | 0.164000 | 1.22e-02 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 1.50e-01 | -0.163000 | 4.46e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.75e-01 | 0.163000 | 4.78e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 1.08e-02 | 0.163000 | 9.12e-02 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 3.09e-01 | -0.163000 | 6.09e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 9.57e-02 | 0.163000 | 3.60e-01 |
PYRUVATE METABOLISM | 27 | 1.43e-01 | -0.163000 | 4.38e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 2.92e-01 | -0.163000 | 5.95e-01 |
PI METABOLISM | 79 | 1.25e-02 | -0.163000 | 1.01e-01 |
PECAM1 INTERACTIONS | 12 | 3.31e-01 | -0.162000 | 6.27e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 2.77e-01 | 0.162000 | 5.89e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 3.75e-01 | -0.162000 | 6.73e-01 |
DAP12 SIGNALING | 24 | 1.69e-01 | -0.162000 | 4.69e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 1.69e-01 | 0.162000 | 4.69e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 37 | 8.95e-02 | 0.161000 | 3.45e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 9.13e-02 | -0.160000 | 3.49e-01 |
DNA METHYLATION | 22 | 1.93e-01 | 0.160000 | 4.98e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 1.67e-01 | 0.160000 | 4.66e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 1.12e-01 | 0.160000 | 3.91e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 3.40e-02 | 0.160000 | 1.93e-01 |
DISEASES OF GLYCOSYLATION | 125 | 2.11e-03 | 0.159000 | 2.99e-02 |
NEUREXINS AND NEUROLIGINS | 54 | 4.29e-02 | -0.159000 | 2.22e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 114 | 3.37e-03 | 0.159000 | 4.02e-02 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 1.20e-01 | -0.159000 | 4.00e-01 |
LAGGING STRAND SYNTHESIS | 20 | 2.19e-01 | 0.159000 | 5.31e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 3.23e-01 | 0.158000 | 6.22e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 3.87e-01 | 0.158000 | 6.79e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 31 | 1.29e-01 | 0.158000 | 4.21e-01 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.38e-03 | 0.157000 | 3.16e-02 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 2.48e-01 | -0.157000 | 5.59e-01 |
FANCONI ANEMIA PATHWAY | 36 | 1.03e-01 | 0.157000 | 3.76e-01 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 6.10e-03 | 0.157000 | 6.20e-02 |
CILIUM ASSEMBLY | 191 | 1.89e-04 | 0.157000 | 5.32e-03 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 1.45e-01 | -0.157000 | 4.39e-01 |
FOXO MEDIATED TRANSCRIPTION | 58 | 3.94e-02 | -0.156000 | 2.12e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 1.40e-01 | -0.156000 | 4.37e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 2.81e-01 | 0.156000 | 5.91e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 1.88e-01 | 0.155000 | 4.91e-01 |
KILLING MECHANISMS | 11 | 3.73e-01 | 0.155000 | 6.72e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 3.33e-01 | 0.155000 | 6.27e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 25 | 1.80e-01 | 0.155000 | 4.86e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 3.00e-01 | 0.155000 | 6.01e-01 |
RAC3 GTPASE CYCLE | 90 | 1.13e-02 | -0.155000 | 9.42e-02 |
PI 3K CASCADE FGFR2 | 16 | 2.85e-01 | -0.154000 | 5.93e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 34 | 1.20e-01 | 0.154000 | 4.00e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 2.01e-01 | -0.154000 | 5.09e-01 |
NEURONAL SYSTEM | 369 | 4.04e-07 | -0.154000 | 7.94e-05 |
GOLGI TO ER RETROGRADE TRANSPORT | 119 | 4.06e-03 | 0.153000 | 4.64e-02 |
ANTIMICROBIAL PEPTIDES | 18 | 2.63e-01 | 0.152000 | 5.72e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 16 | 2.91e-01 | 0.152000 | 5.95e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 1.43e-01 | -0.152000 | 4.37e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 1.25e-01 | -0.152000 | 4.09e-01 |
SIGNALING BY NOTCH4 | 83 | 1.70e-02 | 0.152000 | 1.16e-01 |
MUSCLE CONTRACTION | 162 | 8.77e-04 | -0.152000 | 1.52e-02 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 2.94e-01 | -0.152000 | 5.95e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 1.16e-01 | -0.151000 | 3.98e-01 |
GLYCOGEN METABOLISM | 25 | 1.92e-01 | 0.151000 | 4.98e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 14 | 3.29e-01 | 0.151000 | 6.27e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 1.30e-01 | 0.150000 | 4.22e-01 |
METABOLISM OF CARBOHYDRATES | 258 | 3.51e-05 | 0.150000 | 1.59e-03 |
PROTEIN LOCALIZATION | 156 | 1.42e-03 | 0.148000 | 2.23e-02 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 2.00e-01 | -0.148000 | 5.09e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.91e-01 | -0.148000 | 5.95e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 1.92e-01 | -0.148000 | 4.96e-01 |
PLATELET HOMEOSTASIS | 79 | 2.30e-02 | -0.148000 | 1.44e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.96e-01 | -0.148000 | 6.87e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 3.75e-01 | 0.148000 | 6.73e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 7.51e-02 | 0.147000 | 3.08e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 3.81e-01 | -0.146000 | 6.74e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 1.35e-01 | -0.146000 | 4.28e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 97 | 1.33e-02 | 0.146000 | 1.03e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 4.41e-02 | 0.146000 | 2.22e-01 |
INFLAMMASOMES | 19 | 2.73e-01 | 0.145000 | 5.86e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 3.86e-01 | 0.145000 | 6.77e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 13 | 3.69e-01 | 0.144000 | 6.67e-01 |
RAC1 GTPASE CYCLE | 178 | 9.53e-04 | -0.144000 | 1.62e-02 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 42 | 1.08e-01 | 0.143000 | 3.82e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 4.81e-02 | 0.143000 | 2.29e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 1.85e-01 | -0.142000 | 4.89e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 1.51e-01 | -0.142000 | 4.46e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 3.10e-01 | 0.142000 | 6.10e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 2.85e-01 | -0.142000 | 5.93e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 4.16e-01 | 0.142000 | 6.99e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.41e-01 | -0.141000 | 5.53e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 118 | 8.26e-03 | 0.141000 | 7.44e-02 |
ERK MAPK TARGETS | 22 | 2.54e-01 | -0.140000 | 5.62e-01 |
RHOU GTPASE CYCLE | 33 | 1.63e-01 | -0.140000 | 4.64e-01 |
DISEASES OF DNA REPAIR | 11 | 4.22e-01 | 0.140000 | 7.05e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 3.33e-01 | 0.140000 | 6.27e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 4.23e-01 | 0.139000 | 7.06e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 2.10e-01 | -0.139000 | 5.19e-01 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 3.69e-01 | 0.139000 | 6.67e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 3.22e-01 | -0.139000 | 6.22e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 1.50e-01 | -0.139000 | 4.46e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 91 | 2.26e-02 | 0.138000 | 1.42e-01 |
CIRCADIAN CLOCK | 68 | 4.92e-02 | -0.138000 | 2.32e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 2.63e-01 | -0.138000 | 5.72e-01 |
PLATELET CALCIUM HOMEOSTASIS | 27 | 2.16e-01 | -0.137000 | 5.27e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 4.10e-01 | -0.137000 | 6.99e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 4.30e-01 | 0.137000 | 7.11e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 3.27e-01 | -0.137000 | 6.27e-01 |
GLUCOSE METABOLISM | 80 | 3.43e-02 | 0.137000 | 1.93e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 3.93e-01 | -0.137000 | 6.85e-01 |
NETRIN 1 SIGNALING | 49 | 9.83e-02 | -0.137000 | 3.64e-01 |
INWARDLY RECTIFYING K CHANNELS | 32 | 1.82e-01 | -0.136000 | 4.86e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 5.10e-03 | 0.136000 | 5.49e-02 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 17 | 3.32e-01 | -0.136000 | 6.27e-01 |
CYTOPROTECTION BY HMOX1 | 119 | 1.06e-02 | 0.136000 | 9.12e-02 |
GLYCOGEN SYNTHESIS | 14 | 3.80e-01 | 0.135000 | 6.74e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.59e-01 | 0.135000 | 7.35e-01 |
INTERLEUKIN 7 SIGNALING | 19 | 3.07e-01 | 0.135000 | 6.06e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.81e-01 | 0.135000 | 6.74e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 1.50e-01 | 0.135000 | 4.46e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 4.80e-02 | -0.135000 | 2.29e-01 |
DNA REPLICATION PRE INITIATION | 79 | 3.84e-02 | 0.135000 | 2.09e-01 |
PROCESSING OF SMDT1 | 16 | 3.52e-01 | 0.134000 | 6.51e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 32 | 1.89e-01 | 0.134000 | 4.91e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 2.13e-01 | 0.134000 | 5.23e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 4.43e-01 | -0.134000 | 7.19e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 3.42e-01 | 0.133000 | 6.37e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 2.61e-01 | 0.133000 | 5.71e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 2.83e-01 | 0.132000 | 5.92e-01 |
PI 3K CASCADE FGFR4 | 12 | 4.29e-01 | -0.132000 | 7.10e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 3.20e-01 | 0.132000 | 6.22e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 2.21e-01 | 0.131000 | 5.33e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 3.64e-01 | 0.131000 | 6.61e-01 |
PI 3K CASCADE FGFR3 | 13 | 4.15e-01 | -0.131000 | 6.99e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 4.50e-02 | 0.130000 | 2.24e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 3.79e-02 | -0.130000 | 2.07e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 2.02e-01 | -0.130000 | 5.09e-01 |
CRISTAE FORMATION | 31 | 2.12e-01 | 0.130000 | 5.21e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 4.02e-01 | 0.129000 | 6.92e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 70 | 6.21e-02 | 0.129000 | 2.76e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 94 | 3.08e-02 | -0.129000 | 1.77e-01 |
EPHRIN SIGNALING | 19 | 3.30e-01 | 0.129000 | 6.27e-01 |
TELOMERE MAINTENANCE | 80 | 4.64e-02 | 0.129000 | 2.27e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 151 | 6.61e-03 | 0.128000 | 6.55e-02 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 1.04e-01 | -0.128000 | 3.77e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 3.81e-01 | -0.127000 | 6.74e-01 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 7.35e-02 | 0.126000 | 3.05e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 94 | 3.49e-02 | 0.126000 | 1.96e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 9.62e-02 | 0.125000 | 3.60e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 2.70e-01 | 0.125000 | 5.82e-01 |
SEPARATION OF SISTER CHROMATIDS | 166 | 5.50e-03 | 0.125000 | 5.69e-02 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 4.35e-01 | -0.125000 | 7.11e-01 |
SIGNALING BY ERBB2 | 48 | 1.35e-01 | -0.125000 | 4.28e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 3.22e-01 | 0.125000 | 6.22e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 2.39e-01 | -0.124000 | 5.53e-01 |
SIGNALING BY ROBO RECEPTORS | 205 | 2.26e-03 | 0.124000 | 3.13e-02 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 172 | 5.31e-03 | 0.123000 | 5.64e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 4.13e-02 | 0.123000 | 2.17e-01 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 3.81e-01 | -0.123000 | 6.74e-01 |
PURINE SALVAGE | 12 | 4.61e-01 | 0.123000 | 7.37e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 1.42e-01 | 0.123000 | 4.37e-01 |
SYNTHESIS OF PA | 29 | 2.54e-01 | 0.122000 | 5.62e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 4.63e-01 | -0.122000 | 7.38e-01 |
COSTIMULATION BY THE CD28 FAMILY | 50 | 1.35e-01 | -0.122000 | 4.28e-01 |
GLYCOLYSIS | 66 | 8.65e-02 | 0.122000 | 3.36e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 22 | 3.22e-01 | -0.122000 | 6.22e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 3.70e-01 | 0.122000 | 6.68e-01 |
BASE EXCISION REPAIR | 58 | 1.09e-01 | 0.122000 | 3.84e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 3.58e-01 | 0.122000 | 6.55e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 2.49e-01 | 0.122000 | 5.59e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 4.00e-01 | -0.121000 | 6.91e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 44 | 1.65e-01 | -0.121000 | 4.66e-01 |
RHOF GTPASE CYCLE | 40 | 1.86e-01 | -0.121000 | 4.89e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 4.34e-01 | -0.121000 | 7.11e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 4.70e-01 | -0.121000 | 7.38e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 3.78e-01 | -0.120000 | 6.74e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 31 | 2.48e-01 | -0.120000 | 5.59e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 3.20e-01 | -0.120000 | 6.22e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.92e-01 | -0.120000 | 7.58e-01 |
SIALIC ACID METABOLISM | 32 | 2.43e-01 | -0.119000 | 5.54e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 4.24e-01 | 0.119000 | 7.06e-01 |
METABOLISM OF AMINE DERIVED HORMONES | 10 | 5.14e-01 | 0.119000 | 7.70e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 4.25e-01 | -0.119000 | 7.06e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 4.31e-02 | -0.119000 | 2.22e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 3.14e-01 | 0.119000 | 6.15e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 52 | 1.40e-01 | 0.118000 | 4.37e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 4.97e-01 | 0.118000 | 7.60e-01 |
IRS MEDIATED SIGNALLING | 39 | 2.01e-01 | -0.118000 | 5.09e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 4.61e-01 | 0.118000 | 7.37e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 3.51e-01 | -0.118000 | 6.50e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 1.72e-01 | -0.118000 | 4.72e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.00e-01 | -0.117000 | 6.01e-01 |
REGULATION OF IFNG SIGNALING | 13 | 4.65e-01 | 0.117000 | 7.38e-01 |
DNA REPLICATION | 121 | 2.65e-02 | 0.117000 | 1.57e-01 |
REGULATION OF FZD BY UBIQUITINATION | 20 | 3.66e-01 | 0.117000 | 6.62e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 4.20e-01 | 0.117000 | 7.03e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 241 | 1.91e-03 | -0.116000 | 2.82e-02 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 6.48e-02 | 0.115000 | 2.79e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 11 | 5.09e-01 | 0.115000 | 7.65e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 5.09e-01 | -0.115000 | 7.65e-01 |
INFLUENZA INFECTION | 145 | 1.69e-02 | 0.115000 | 1.16e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 61 | 1.22e-01 | -0.115000 | 4.03e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 4.59e-02 | 0.114000 | 2.26e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 2.64e-01 | -0.114000 | 5.73e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 1.67e-01 | -0.114000 | 4.67e-01 |
CLEC7A DECTIN 1 SIGNALING | 95 | 5.53e-02 | 0.114000 | 2.51e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 1.97e-01 | -0.114000 | 5.04e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 3.81e-01 | -0.113000 | 6.74e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 2.05e-01 | -0.113000 | 5.12e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 1.55e-01 | 0.113000 | 4.51e-01 |
RNA POLYMERASE I TRANSCRIPTION | 69 | 1.05e-01 | 0.113000 | 3.77e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 1.06e-01 | 0.113000 | 3.77e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 3.62e-01 | 0.112000 | 6.59e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 5.02e-01 | 0.112000 | 7.64e-01 |
TNF SIGNALING | 43 | 2.04e-01 | 0.112000 | 5.11e-01 |
RHOBTB GTPASE CYCLE | 35 | 2.52e-01 | -0.112000 | 5.62e-01 |
METHYLATION | 12 | 5.05e-01 | 0.111000 | 7.64e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 52 | 1.66e-01 | 0.111000 | 4.66e-01 |
LAMININ INTERACTIONS | 29 | 3.03e-01 | -0.111000 | 6.04e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 180 | 1.07e-02 | -0.110000 | 9.12e-02 |
REPRESSION OF WNT TARGET GENES | 14 | 4.74e-01 | 0.110000 | 7.43e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 121 | 3.62e-02 | 0.110000 | 2.00e-01 |
CELL JUNCTION ORGANIZATION | 73 | 1.03e-01 | -0.110000 | 3.77e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.82e-01 | 0.110000 | 6.74e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 2.40e-01 | 0.110000 | 5.53e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 4.34e-01 | -0.110000 | 7.11e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 1.94e-01 | 0.109000 | 4.99e-01 |
SLC TRANSPORTER DISORDERS | 76 | 1.00e-01 | -0.109000 | 3.68e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 4.96e-01 | -0.109000 | 7.60e-01 |
FORMATION OF APOPTOSOME | 10 | 5.51e-01 | -0.109000 | 7.89e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 2.65e-01 | 0.109000 | 5.73e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 4.51e-01 | -0.109000 | 7.29e-01 |
RETINOID CYCLE DISEASE EVENTS | 10 | 5.52e-01 | 0.109000 | 7.89e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 4.12e-01 | 0.109000 | 6.99e-01 |
COLLAGEN CHAIN TRIMERIZATION | 40 | 2.36e-01 | 0.108000 | 5.48e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 4.14e-01 | -0.108000 | 6.99e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 286 | 1.68e-03 | 0.108000 | 2.50e-02 |
PI 3K CASCADE FGFR1 | 15 | 4.69e-01 | -0.108000 | 7.38e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 22 | 3.82e-01 | -0.108000 | 6.74e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 5.20e-01 | -0.107000 | 7.74e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 62 | 1.44e-01 | 0.107000 | 4.39e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 4.73e-01 | -0.107000 | 7.41e-01 |
METABOLISM OF RNA | 644 | 4.05e-06 | 0.107000 | 3.67e-04 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 5.40e-01 | -0.107000 | 7.82e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 4.34e-01 | -0.107000 | 7.11e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 9.34e-02 | 0.107000 | 3.53e-01 |
LGI ADAM INTERACTIONS | 14 | 4.90e-01 | -0.107000 | 7.58e-01 |
RHOV GTPASE CYCLE | 32 | 2.97e-01 | -0.106000 | 5.99e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 28 | 3.33e-01 | -0.106000 | 6.27e-01 |
MITOTIC METAPHASE AND ANAPHASE | 207 | 8.87e-03 | 0.106000 | 7.86e-02 |
DISEASES OF PROGRAMMED CELL DEATH | 56 | 1.72e-01 | 0.105000 | 4.72e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 4.28e-01 | 0.105000 | 7.10e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 3.04e-01 | -0.105000 | 6.05e-01 |
MITOTIC G2 G2 M PHASES | 184 | 1.44e-02 | 0.105000 | 1.07e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 5.30e-01 | -0.105000 | 7.79e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 4.98e-01 | 0.105000 | 7.61e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 8.38e-02 | 0.104000 | 3.27e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 3.01e-01 | -0.104000 | 6.01e-01 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 5.70e-01 | -0.104000 | 8.02e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 58 | 1.73e-01 | -0.104000 | 4.72e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 3.19e-01 | 0.103000 | 6.22e-01 |
CELL CELL COMMUNICATION | 106 | 6.63e-02 | -0.103000 | 2.83e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 3.12e-01 | -0.103000 | 6.13e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 4.91e-01 | -0.103000 | 7.58e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 1.72e-01 | 0.103000 | 4.72e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 4.16e-01 | -0.103000 | 6.99e-01 |
SUMOYLATION | 165 | 2.45e-02 | -0.102000 | 1.49e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 2.50e-01 | -0.101000 | 5.61e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 1.65e-01 | -0.101000 | 4.66e-01 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 5.79e-01 | 0.101000 | 8.07e-01 |
VISUAL PHOTOTRANSDUCTION | 63 | 1.66e-01 | 0.101000 | 4.66e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 64 | 1.66e-01 | 0.100000 | 4.66e-01 |
RHOG GTPASE CYCLE | 73 | 1.39e-01 | -0.100000 | 4.37e-01 |
EXTENSION OF TELOMERES | 49 | 2.26e-01 | 0.100000 | 5.38e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 3.28e-01 | 0.100000 | 6.27e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.38e-02 | 0.100000 | 1.46e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 5.33e-01 | -0.099900 | 7.79e-01 |
TBC RABGAPS | 43 | 2.59e-01 | 0.099600 | 5.69e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 4.09e-01 | 0.099400 | 6.99e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 5.52e-01 | 0.099100 | 7.89e-01 |
MITOPHAGY | 29 | 3.56e-01 | 0.099000 | 6.55e-01 |
GLUTATHIONE CONJUGATION | 29 | 3.57e-01 | 0.098800 | 6.55e-01 |
PTEN REGULATION | 133 | 4.97e-02 | 0.098700 | 2.32e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.38e-01 | 0.098600 | 7.81e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 3.44e-01 | -0.098200 | 6.41e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 2.71e-01 | 0.098100 | 5.84e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 5.40e-01 | 0.098100 | 7.82e-01 |
MRNA SPLICING | 188 | 2.06e-02 | 0.098000 | 1.34e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 12 | 5.57e-01 | -0.098000 | 7.92e-01 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 5.92e-01 | -0.097900 | 8.17e-01 |
RHOD GTPASE CYCLE | 50 | 2.32e-01 | -0.097800 | 5.43e-01 |
ION TRANSPORT BY P TYPE ATPASES | 49 | 2.39e-01 | -0.097200 | 5.53e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 5.79e-01 | 0.096700 | 8.07e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 2.75e-01 | 0.096300 | 5.87e-01 |
PRC2 METHYLATES HISTONES AND DNA | 31 | 3.54e-01 | 0.096300 | 6.53e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 3.26e-01 | -0.096000 | 6.25e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 89 | 1.18e-01 | -0.095800 | 3.98e-01 |
SIGNALING BY NODAL | 15 | 5.22e-01 | -0.095500 | 7.74e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 3.37e-01 | -0.095100 | 6.32e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 3.94e-01 | -0.094800 | 6.85e-01 |
SIGNALING BY ACTIVIN | 12 | 5.71e-01 | -0.094500 | 8.02e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 4.76e-01 | 0.094400 | 7.45e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 5.59e-01 | 0.093600 | 7.93e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 6.09e-01 | -0.093300 | 8.22e-01 |
METABOLISM OF COFACTORS | 19 | 4.83e-01 | 0.093000 | 7.53e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 3.05e-01 | -0.092700 | 6.05e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 2.27e-01 | 0.092600 | 5.39e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 5.97e-01 | -0.092200 | 8.17e-01 |
SIGNALING BY ERBB4 | 57 | 2.31e-01 | -0.091700 | 5.43e-01 |
CS DS DEGRADATION | 14 | 5.53e-01 | 0.091500 | 7.89e-01 |
HCMV INFECTION | 105 | 1.06e-01 | 0.091400 | 3.77e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 3.65e-01 | 0.091200 | 6.61e-01 |
HYALURONAN METABOLISM | 15 | 5.43e-01 | 0.090800 | 7.84e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 5.30e-01 | 0.090600 | 7.79e-01 |
RND1 GTPASE CYCLE | 38 | 3.35e-01 | -0.090400 | 6.29e-01 |
RHOB GTPASE CYCLE | 67 | 2.03e-01 | -0.090100 | 5.09e-01 |
G ALPHA I SIGNALLING EVENTS | 206 | 2.61e-02 | -0.090100 | 1.55e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 23 | 4.57e-01 | 0.089600 | 7.33e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 6.25e-01 | -0.089300 | 8.27e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 5.64e-01 | -0.089100 | 7.95e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 4.15e-01 | 0.089100 | 6.99e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 6.26e-01 | 0.089100 | 8.27e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 5.04e-01 | -0.088600 | 7.64e-01 |
CD28 CO STIMULATION | 31 | 3.93e-01 | -0.088600 | 6.85e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 4.29e-01 | 0.087900 | 7.10e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 45 | 3.08e-01 | -0.087900 | 6.06e-01 |
STIMULI SENSING CHANNELS | 76 | 1.85e-01 | -0.087900 | 4.89e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 4.66e-01 | -0.087900 | 7.38e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 179 | 4.29e-02 | 0.087800 | 2.22e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 5.21e-01 | 0.087400 | 7.74e-01 |
PROTEIN METHYLATION | 17 | 5.33e-01 | 0.087400 | 7.79e-01 |
BIOLOGICAL OXIDATIONS | 127 | 9.20e-02 | 0.086600 | 3.49e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 604 | 2.97e-04 | 0.086500 | 7.30e-03 |
METABOLISM OF VITAMINS AND COFACTORS | 156 | 6.29e-02 | 0.086400 | 2.77e-01 |
AMYLOID FIBER FORMATION | 60 | 2.48e-01 | 0.086300 | 5.59e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 69 | 2.16e-01 | -0.086300 | 5.26e-01 |
SIGNALING BY SCF KIT | 41 | 3.40e-01 | -0.086200 | 6.34e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 5.05e-01 | 0.086200 | 7.64e-01 |
MEIOTIC RECOMBINATION | 40 | 3.46e-01 | -0.086200 | 6.43e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 6.21e-01 | -0.086000 | 8.26e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 2.75e-01 | -0.085200 | 5.87e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 5.95e-01 | -0.085200 | 8.17e-01 |
HCMV EARLY EVENTS | 82 | 1.83e-01 | 0.085100 | 4.87e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 283 | 1.40e-02 | 0.085000 | 1.07e-01 |
G2 M DNA DAMAGE CHECKPOINT | 66 | 2.36e-01 | -0.084400 | 5.48e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 6.44e-01 | -0.084400 | 8.36e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 6.44e-01 | -0.084400 | 8.36e-01 |
INTERLEUKIN 27 SIGNALING | 10 | 6.44e-01 | -0.084300 | 8.36e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 4.34e-01 | -0.083900 | 7.11e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 19 | 5.27e-01 | -0.083800 | 7.78e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 2.04e-01 | 0.083800 | 5.11e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 3.32e-01 | -0.083500 | 6.27e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 5.18e-01 | 0.083500 | 7.73e-01 |
METABOLISM OF STEROIDS | 116 | 1.20e-01 | 0.083500 | 4.00e-01 |
MEIOSIS | 66 | 2.41e-01 | -0.083500 | 5.53e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 1.35e-01 | -0.083300 | 4.28e-01 |
REPRODUCTION | 79 | 2.02e-01 | -0.083200 | 5.09e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 3.57e-01 | 0.083100 | 6.55e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 5.78e-01 | -0.083000 | 8.06e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 6.05e-01 | 0.082800 | 8.22e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 4.67e-01 | 0.082400 | 7.38e-01 |
TCR SIGNALING | 100 | 1.55e-01 | 0.082300 | 4.51e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 4.95e-01 | 0.082300 | 7.60e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 5.45e-02 | 0.082100 | 2.50e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 139 | 9.61e-02 | 0.081800 | 3.60e-01 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 5.16e-01 | 0.081800 | 7.73e-01 |
SIGNALING BY FGFR1 | 43 | 3.56e-01 | -0.081400 | 6.55e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 2.93e-01 | -0.081200 | 5.95e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 4.91e-01 | 0.081200 | 7.58e-01 |
ESR MEDIATED SIGNALING | 169 | 6.93e-02 | -0.081100 | 2.92e-01 |
FERTILIZATION | 13 | 6.14e-01 | -0.080700 | 8.22e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 5.66e-01 | 0.080400 | 7.97e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 2.91e-01 | -0.079500 | 5.95e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1090 | 1.15e-05 | -0.079300 | 7.15e-04 |
INTERLEUKIN 6 FAMILY SIGNALING | 20 | 5.41e-01 | 0.079000 | 7.82e-01 |
RAS PROCESSING | 24 | 5.03e-01 | 0.078900 | 7.64e-01 |
FLT3 SIGNALING | 36 | 4.16e-01 | -0.078400 | 6.99e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 86 | 2.10e-01 | -0.078300 | 5.19e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 6.13e-01 | 0.078200 | 8.22e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 6.13e-01 | 0.078000 | 8.22e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 4.92e-01 | 0.077900 | 7.58e-01 |
PI3K AKT SIGNALING IN CANCER | 88 | 2.10e-01 | -0.077400 | 5.19e-01 |
SIGNALING BY FGFR2 | 63 | 2.89e-01 | 0.077200 | 5.95e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 4.96e-01 | 0.077200 | 7.60e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 20 | 5.54e-01 | 0.076500 | 7.89e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 67 | 2.79e-01 | 0.076500 | 5.90e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 2.25e-01 | 0.076200 | 5.37e-01 |
ELASTIC FIBRE FORMATION | 38 | 4.17e-01 | 0.076100 | 6.99e-01 |
UNWINDING OF DNA | 12 | 6.50e-01 | -0.075800 | 8.38e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 2.33e-01 | -0.075700 | 5.45e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 107 | 1.81e-01 | 0.075000 | 4.86e-01 |
LYSOSOME VESICLE BIOGENESIS | 32 | 4.64e-01 | 0.074800 | 7.38e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 4.33e-01 | 0.074500 | 7.11e-01 |
GABA B RECEPTOR ACTIVATION | 40 | 4.16e-01 | -0.074400 | 6.99e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 6.07e-01 | -0.074400 | 8.22e-01 |
LYSINE CATABOLISM | 11 | 6.72e-01 | 0.073800 | 8.56e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 6.88e-01 | -0.073400 | 8.61e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 49 | 3.76e-01 | 0.073100 | 6.73e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 6.03e-01 | 0.072900 | 8.22e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 6.64e-01 | 0.072400 | 8.50e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 6.39e-01 | 0.072400 | 8.34e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 6.16e-01 | 0.072400 | 8.22e-01 |
NICOTINATE METABOLISM | 25 | 5.31e-01 | -0.072400 | 7.79e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 4.47e-01 | -0.072300 | 7.24e-01 |
PKMTS METHYLATE HISTONE LYSINES | 49 | 3.82e-01 | -0.072200 | 6.74e-01 |
HOST INTERACTIONS OF HIV FACTORS | 124 | 1.67e-01 | 0.072000 | 4.66e-01 |
PEROXISOMAL PROTEIN IMPORT | 57 | 3.48e-01 | 0.071800 | 6.47e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 48 | 3.89e-01 | 0.071800 | 6.81e-01 |
DNA DAMAGE BYPASS | 46 | 4.00e-01 | -0.071800 | 6.91e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 26 | 5.28e-01 | 0.071500 | 7.78e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 5.29e-01 | 0.071400 | 7.78e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 44 | 4.15e-01 | -0.071100 | 6.99e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 5.74e-01 | -0.070800 | 8.04e-01 |
DNA STRAND ELONGATION | 32 | 4.88e-01 | 0.070800 | 7.58e-01 |
EGFR DOWNREGULATION | 28 | 5.18e-01 | -0.070500 | 7.73e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 5.95e-01 | 0.070500 | 8.17e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 33 | 4.85e-01 | 0.070200 | 7.55e-01 |
RHO GTPASE CYCLE | 426 | 1.33e-02 | -0.070100 | 1.03e-01 |
TOLL LIKE RECEPTOR CASCADES | 137 | 1.58e-01 | -0.070000 | 4.54e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 23 | 5.62e-01 | 0.069900 | 7.95e-01 |
P38MAPK EVENTS | 12 | 6.75e-01 | 0.069900 | 8.56e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 541 | 5.61e-03 | -0.069900 | 5.75e-02 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 4.34e-01 | -0.069800 | 7.11e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 90 | 2.54e-01 | -0.069600 | 5.62e-01 |
NEDDYLATION | 219 | 7.66e-02 | 0.069500 | 3.10e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 45 | 4.20e-01 | 0.069400 | 7.03e-01 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 6.95e-01 | -0.068300 | 8.63e-01 |
C TYPE LECTIN RECEPTORS CLRS | 113 | 2.11e-01 | 0.068100 | 5.21e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 5.98e-01 | 0.068100 | 8.18e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 20 | 6.00e-01 | 0.067700 | 8.20e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 49 | 4.14e-01 | 0.067500 | 6.99e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 4.55e-01 | -0.066700 | 7.31e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 13 | 6.77e-01 | 0.066700 | 8.56e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 3.64e-01 | 0.066700 | 6.61e-01 |
PLASMA LIPOPROTEIN REMODELING | 17 | 6.35e-01 | 0.066600 | 8.31e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 5.82e-01 | -0.066300 | 8.09e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 6.93e-01 | 0.065800 | 8.63e-01 |
SIGNALING BY EGFR | 47 | 4.35e-01 | -0.065800 | 7.11e-01 |
G ALPHA Z SIGNALLING EVENTS | 46 | 4.41e-01 | -0.065700 | 7.17e-01 |
INTERLEUKIN 17 SIGNALING | 67 | 3.53e-01 | -0.065600 | 6.53e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 4.13e-01 | -0.065600 | 6.99e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 7.06e-01 | 0.065600 | 8.68e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 243 | 8.15e-02 | 0.065000 | 3.23e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 2.82e-01 | -0.065000 | 5.91e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 48 | 4.38e-01 | -0.064700 | 7.15e-01 |
CHROMOSOME MAINTENANCE | 103 | 2.59e-01 | 0.064400 | 5.69e-01 |
RND2 GTPASE CYCLE | 38 | 4.93e-01 | -0.064300 | 7.59e-01 |
MITOTIC PROPHASE | 96 | 2.77e-01 | -0.064200 | 5.89e-01 |
SIGNALING BY NOTCH3 | 48 | 4.42e-01 | -0.064200 | 7.17e-01 |
MRNA CAPPING | 29 | 5.50e-01 | 0.064100 | 7.89e-01 |
SIGNALING BY NOTCH | 189 | 1.30e-01 | 0.064000 | 4.22e-01 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 7.27e-01 | -0.063900 | 8.78e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 5.74e-01 | 0.063700 | 8.04e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 141 | 1.93e-01 | 0.063600 | 4.98e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 95 | 2.87e-01 | 0.063300 | 5.94e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 6.26e-01 | 0.063000 | 8.27e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 7.18e-01 | -0.063000 | 8.70e-01 |
CDC42 GTPASE CYCLE | 153 | 1.79e-01 | -0.063000 | 4.86e-01 |
SARS COV 1 INFECTION | 48 | 4.52e-01 | 0.062700 | 7.29e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 6.46e-01 | 0.062600 | 8.36e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 6.29e-01 | -0.062400 | 8.29e-01 |
SIGNALLING TO ERKS | 33 | 5.36e-01 | -0.062300 | 7.80e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 3.97e-01 | -0.062200 | 6.88e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 5.07e-01 | -0.062200 | 7.65e-01 |
NEUTROPHIL DEGRANULATION | 386 | 3.63e-02 | 0.062200 | 2.00e-01 |
REGULATION OF KIT SIGNALING | 16 | 6.67e-01 | -0.062200 | 8.52e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 6.06e-01 | 0.062100 | 8.22e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 12 | 7.10e-01 | -0.062100 | 8.70e-01 |
RHOC GTPASE CYCLE | 73 | 3.61e-01 | -0.061900 | 6.59e-01 |
BASIGIN INTERACTIONS | 22 | 6.15e-01 | -0.061900 | 8.22e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 5.53e-01 | 0.061600 | 7.89e-01 |
SIGNALING BY NOTCH2 | 32 | 5.47e-01 | -0.061500 | 7.89e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 41 | 4.97e-01 | 0.061300 | 7.60e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 192 | 1.45e-01 | -0.061100 | 4.39e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 5.63e-01 | 0.061100 | 7.95e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 6.54e-01 | 0.061000 | 8.41e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 5.27e-01 | -0.061000 | 7.78e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 2.75e-01 | 0.060800 | 5.87e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 4.53e-01 | -0.060800 | 7.30e-01 |
INTERLEUKIN 35 SIGNALLING | 10 | 7.40e-01 | -0.060700 | 8.88e-01 |
G PROTEIN ACTIVATION | 23 | 6.15e-01 | 0.060700 | 8.22e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 6.15e-01 | 0.060600 | 8.22e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 4.68e-01 | -0.060600 | 7.38e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 5.94e-01 | 0.060400 | 8.17e-01 |
SARS COV 2 INFECTION | 65 | 4.01e-01 | 0.060300 | 6.91e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 5.50e-01 | -0.060100 | 7.89e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 19 | 6.52e-01 | -0.059700 | 8.40e-01 |
TRIGLYCERIDE BIOSYNTHESIS | 10 | 7.46e-01 | 0.059100 | 8.92e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 1.19e-01 | 0.058900 | 3.98e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 29 | 5.83e-01 | 0.058900 | 8.10e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 4.68e-01 | 0.058800 | 7.38e-01 |
ERKS ARE INACTIVATED | 13 | 7.14e-01 | -0.058800 | 8.70e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 4.65e-01 | 0.058600 | 7.38e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 106 | 2.98e-01 | 0.058600 | 5.99e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 55 | 4.55e-01 | -0.058300 | 7.31e-01 |
HIV INFECTION | 220 | 1.37e-01 | 0.058300 | 4.33e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 104 | 3.07e-01 | 0.058100 | 6.06e-01 |
SURFACTANT METABOLISM | 16 | 6.88e-01 | 0.058000 | 8.61e-01 |
NEPHRIN FAMILY INTERACTIONS | 23 | 6.30e-01 | -0.058000 | 8.29e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 3.28e-01 | 0.057800 | 6.27e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 6.81e-01 | -0.057700 | 8.56e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 14 | 7.11e-01 | -0.057200 | 8.70e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 6.22e-01 | -0.057000 | 8.26e-01 |
AQUAPORIN MEDIATED TRANSPORT | 40 | 5.36e-01 | -0.056500 | 7.80e-01 |
INOSITOL PHOSPHATE METABOLISM | 47 | 5.03e-01 | -0.056500 | 7.64e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 7.17e-01 | 0.055900 | 8.70e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 6.24e-01 | -0.055600 | 8.27e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 7.61e-01 | 0.055500 | 8.96e-01 |
HOMOLOGY DIRECTED REPAIR | 107 | 3.22e-01 | -0.055500 | 6.22e-01 |
G2 M CHECKPOINTS | 133 | 2.70e-01 | 0.055400 | 5.82e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 5.76e-01 | 0.055400 | 8.05e-01 |
SARS COV INFECTIONS | 140 | 2.59e-01 | 0.055300 | 5.69e-01 |
DISEASES OF IMMUNE SYSTEM | 24 | 6.41e-01 | -0.055100 | 8.35e-01 |
GPCR LIGAND BINDING | 281 | 1.13e-01 | 0.055000 | 3.92e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 4.62e-01 | -0.054900 | 7.37e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 28 | 6.16e-01 | -0.054800 | 8.22e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 6.57e-01 | -0.054700 | 8.44e-01 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 6.12e-01 | -0.054500 | 8.22e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 5.14e-01 | -0.052900 | 7.70e-01 |
ION CHANNEL TRANSPORT | 142 | 2.79e-01 | -0.052700 | 5.90e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 5.61e-01 | -0.052400 | 7.95e-01 |
EPH EPHRIN SIGNALING | 92 | 3.85e-01 | -0.052400 | 6.77e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 7.55e-01 | 0.052100 | 8.94e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 93 | 3.86e-01 | -0.052000 | 6.77e-01 |
SIGNALING BY WNT IN CANCER | 31 | 6.17e-01 | -0.052000 | 8.22e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 6.67e-01 | 0.051800 | 8.52e-01 |
IRON UPTAKE AND TRANSPORT | 51 | 5.24e-01 | 0.051600 | 7.75e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 6.14e-01 | 0.051500 | 8.22e-01 |
UB SPECIFIC PROCESSING PROTEASES | 168 | 2.52e-01 | 0.051300 | 5.62e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 225 | 1.89e-01 | -0.051000 | 4.91e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 6.81e-01 | -0.050600 | 8.56e-01 |
SIGNALING BY NTRKS | 130 | 3.21e-01 | -0.050500 | 6.22e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 2.48e-01 | 0.050100 | 5.59e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 7.37e-01 | 0.050100 | 8.87e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 6.48e-01 | 0.049900 | 8.37e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 6.31e-01 | -0.049800 | 8.30e-01 |
PROTEIN UBIQUITINATION | 70 | 4.72e-01 | -0.049700 | 7.41e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 107 | 3.76e-01 | 0.049600 | 6.73e-01 |
FATTY ACID METABOLISM | 145 | 3.05e-01 | 0.049400 | 6.05e-01 |
S PHASE | 153 | 2.93e-01 | 0.049300 | 5.95e-01 |
INFECTIOUS DISEASE | 737 | 2.36e-02 | 0.049200 | 1.46e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 7.89e-01 | 0.049000 | 9.15e-01 |
ACYL CHAIN REMODELLING OF PC | 16 | 7.35e-01 | -0.049000 | 8.86e-01 |
SIGNALING BY INSULIN RECEPTOR | 63 | 5.06e-01 | -0.048400 | 7.65e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 6.78e-01 | -0.048000 | 8.56e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 5.88e-01 | 0.047800 | 8.14e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 4.78e-01 | -0.047700 | 7.47e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 7.58e-01 | -0.047500 | 8.95e-01 |
MEIOTIC SYNAPSIS | 42 | 5.96e-01 | 0.047300 | 8.17e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 5.10e-01 | 0.047300 | 7.65e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 7.29e-01 | -0.047200 | 8.80e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 105 | 4.06e-01 | 0.047000 | 6.96e-01 |
LEISHMANIA INFECTION | 201 | 2.52e-01 | -0.047000 | 5.62e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 7.53e-01 | -0.046900 | 8.94e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 20 | 7.17e-01 | 0.046800 | 8.70e-01 |
COMPLEMENT CASCADE | 25 | 6.86e-01 | 0.046700 | 8.61e-01 |
NICOTINAMIDE SALVAGING | 16 | 7.48e-01 | -0.046400 | 8.92e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 5.00e-01 | -0.046300 | 7.63e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 199 | 2.64e-01 | 0.046000 | 5.72e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 7.92e-01 | 0.045800 | 9.17e-01 |
METALLOPROTEASE DUBS | 27 | 6.80e-01 | 0.045800 | 8.56e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 4.89e-01 | -0.045700 | 7.58e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 7.85e-01 | -0.045500 | 9.14e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 7.40e-01 | 0.045200 | 8.88e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 5.36e-01 | 0.045100 | 7.80e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 6.60e-01 | 0.045000 | 8.47e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 6.66e-01 | -0.044800 | 8.51e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 62 | 5.48e-01 | 0.044200 | 7.89e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 30 | 6.76e-01 | -0.044000 | 8.56e-01 |
STRIATED MUSCLE CONTRACTION | 25 | 7.04e-01 | -0.043900 | 8.65e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 6.96e-01 | 0.043500 | 8.63e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 5.93e-01 | 0.043300 | 8.17e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 6.87e-01 | -0.043200 | 8.61e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 4.70e-01 | -0.043200 | 7.38e-01 |
SYNDECAN INTERACTIONS | 27 | 6.99e-01 | 0.043000 | 8.65e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 5.17e-01 | 0.043000 | 7.73e-01 |
DUAL INCISION IN TC NER | 64 | 5.55e-01 | 0.042700 | 7.90e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 467 | 1.17e-01 | -0.042500 | 3.98e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 6.28e-01 | 0.042300 | 8.28e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 7.03e-01 | -0.041700 | 8.65e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 7.95e-01 | -0.041600 | 9.18e-01 |
MET PROMOTES CELL MOTILITY | 39 | 6.54e-01 | -0.041500 | 8.41e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 12 | 8.04e-01 | 0.041400 | 9.19e-01 |
COLLAGEN DEGRADATION | 51 | 6.11e-01 | 0.041200 | 8.22e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 8.22e-01 | -0.041100 | 9.26e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 8.14e-01 | 0.041000 | 9.23e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 3.93e-01 | 0.041000 | 6.85e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 5.35e-01 | 0.040900 | 7.80e-01 |
SIGNALING BY RETINOIC ACID | 32 | 6.89e-01 | 0.040800 | 8.62e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 7.53e-01 | 0.040600 | 8.94e-01 |
CELLULAR SENESCENCE | 144 | 4.06e-01 | 0.040200 | 6.96e-01 |
RND3 GTPASE CYCLE | 37 | 6.74e-01 | -0.040000 | 8.56e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 7.76e-01 | -0.040000 | 9.05e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.17e-01 | 0.039600 | 8.70e-01 |
HEMOSTASIS | 473 | 1.42e-01 | -0.039500 | 4.37e-01 |
PROGRAMMED CELL DEATH | 185 | 3.58e-01 | 0.039300 | 6.55e-01 |
SIGNALLING TO RAS | 19 | 7.69e-01 | 0.039000 | 9.02e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 7.64e-01 | -0.038800 | 8.98e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 8.09e-01 | 0.038600 | 9.21e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 8.10e-01 | -0.038600 | 9.21e-01 |
RHO GTPASE EFFECTORS | 253 | 2.93e-01 | -0.038500 | 5.95e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 8.05e-01 | 0.038200 | 9.19e-01 |
APOPTOSIS | 163 | 4.03e-01 | 0.038000 | 6.93e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 136 | 4.48e-01 | -0.037700 | 7.24e-01 |
M PHASE | 342 | 2.33e-01 | 0.037600 | 5.45e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 105 | 5.08e-01 | -0.037400 | 7.65e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 8.02e-01 | 0.037400 | 9.19e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 7.52e-01 | 0.037300 | 8.94e-01 |
SIGNALING BY GPCR | 497 | 1.59e-01 | -0.037000 | 4.57e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 6.78e-01 | -0.037000 | 8.56e-01 |
NUCLEOBASE CATABOLISM | 31 | 7.23e-01 | 0.036800 | 8.76e-01 |
SENSORY PROCESSING OF SOUND | 62 | 6.17e-01 | 0.036700 | 8.22e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 7.47e-01 | 0.036600 | 8.92e-01 |
NGF STIMULATED TRANSCRIPTION | 37 | 7.01e-01 | -0.036500 | 8.65e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 6.08e-01 | 0.036300 | 8.22e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 28 | 7.41e-01 | -0.036100 | 8.88e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 5.96e-01 | -0.035900 | 8.17e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 7.83e-01 | -0.035600 | 9.13e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 6.44e-01 | 0.035500 | 8.36e-01 |
FRS MEDIATED FGFR4 SIGNALING | 14 | 8.19e-01 | 0.035400 | 9.24e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 5.24e-01 | 0.035300 | 7.75e-01 |
REGULATION OF INSULIN SECRETION | 72 | 6.06e-01 | -0.035200 | 8.22e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 7.39e-01 | 0.035200 | 8.88e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 5.76e-01 | -0.035100 | 8.05e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 8.03e-01 | 0.035000 | 9.19e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 8.08e-01 | 0.035000 | 9.21e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 7.92e-01 | 0.035000 | 9.17e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 37 | 7.13e-01 | -0.035000 | 8.70e-01 |
SIGNALING BY FGFR | 74 | 6.05e-01 | 0.034800 | 8.22e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 7.88e-01 | -0.034800 | 9.15e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 102 | 5.48e-01 | 0.034400 | 7.89e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 46 | 6.90e-01 | 0.034000 | 8.62e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 8.39e-01 | -0.033800 | 9.37e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 631 | 1.50e-01 | -0.033700 | 4.46e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 7.56e-01 | 0.033400 | 8.95e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 6.33e-01 | -0.033200 | 8.31e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 7.74e-01 | 0.033200 | 9.04e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 7.72e-01 | 0.032900 | 9.04e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 7.04e-01 | -0.032800 | 8.65e-01 |
KETONE BODY METABOLISM | 10 | 8.60e-01 | 0.032200 | 9.43e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 7.00e-01 | -0.032100 | 8.65e-01 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 8.30e-01 | 0.032000 | 9.32e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 8.56e-01 | 0.031600 | 9.43e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 8.33e-01 | -0.031500 | 9.33e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 7.48e-01 | 0.031400 | 8.92e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 71 | 6.49e-01 | -0.031300 | 8.38e-01 |
ANCHORING FIBRIL FORMATION | 14 | 8.41e-01 | 0.031000 | 9.37e-01 |
GP1B IX V ACTIVATION SIGNALLING | 10 | 8.65e-01 | -0.031000 | 9.43e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 80 | 6.34e-01 | 0.030800 | 8.31e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 8.13e-01 | -0.030600 | 9.23e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 8.04e-01 | 0.029900 | 9.19e-01 |
SNRNP ASSEMBLY | 51 | 7.12e-01 | -0.029800 | 8.70e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 8.09e-01 | 0.029800 | 9.21e-01 |
ECM PROTEOGLYCANS | 67 | 6.76e-01 | 0.029500 | 8.56e-01 |
SIGNALING BY FGFR IN DISEASE | 55 | 7.08e-01 | -0.029200 | 8.69e-01 |
SIGNALING BY PDGF | 57 | 7.03e-01 | 0.029200 | 8.65e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 7.59e-01 | -0.029200 | 8.95e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 6.40e-01 | -0.029100 | 8.34e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 118 | 5.88e-01 | 0.028900 | 8.14e-01 |
RHOH GTPASE CYCLE | 37 | 7.62e-01 | -0.028800 | 8.96e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 7.94e-01 | -0.028600 | 9.17e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 6.94e-01 | 0.028000 | 8.63e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 7.68e-01 | -0.028000 | 9.02e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 7.55e-01 | 0.027900 | 8.94e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 6.78e-01 | -0.027800 | 8.56e-01 |
RHOA GTPASE CYCLE | 142 | 5.74e-01 | -0.027400 | 8.04e-01 |
TRIGLYCERIDE METABOLISM | 24 | 8.17e-01 | -0.027400 | 9.23e-01 |
INTRA GOLGI TRAFFIC | 43 | 7.57e-01 | -0.027300 | 8.95e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 8.70e-01 | -0.027300 | 9.47e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 7.18e-01 | -0.027200 | 8.70e-01 |
FRS MEDIATED FGFR1 SIGNALING | 17 | 8.47e-01 | 0.027000 | 9.39e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 281 | 4.40e-01 | -0.026800 | 7.16e-01 |
VESICLE MEDIATED TRANSPORT | 611 | 2.60e-01 | 0.026800 | 5.69e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.03e-01 | -0.026800 | 9.19e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 8.03e-01 | 0.026700 | 9.19e-01 |
INTEGRATION OF ENERGY METABOLISM | 99 | 6.47e-01 | 0.026600 | 8.37e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 8.18e-01 | 0.026600 | 9.24e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 8.57e-01 | -0.026100 | 9.43e-01 |
DEATH RECEPTOR SIGNALLING | 133 | 6.10e-01 | -0.025600 | 8.22e-01 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 8.64e-01 | 0.025500 | 9.43e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 6.80e-01 | -0.025400 | 8.56e-01 |
METABOLISM OF PORPHYRINS | 19 | 8.49e-01 | -0.025300 | 9.39e-01 |
PYRIMIDINE CATABOLISM | 10 | 8.91e-01 | 0.025100 | 9.57e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.86e-01 | -0.024900 | 9.54e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 8.47e-01 | -0.024900 | 9.39e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 8.83e-01 | 0.024600 | 9.52e-01 |
NCAM1 INTERACTIONS | 41 | 7.89e-01 | 0.024200 | 9.15e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 8.50e-01 | 0.023800 | 9.39e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 75 | 7.24e-01 | -0.023600 | 8.76e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 19 | 8.59e-01 | 0.023500 | 9.43e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 6.95e-01 | -0.023400 | 8.63e-01 |
O LINKED GLYCOSYLATION | 85 | 7.11e-01 | 0.023200 | 8.70e-01 |
PHOSPHOLIPID METABOLISM | 185 | 5.89e-01 | -0.023100 | 8.14e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 120 | 6.63e-01 | 0.023000 | 8.50e-01 |
RAF ACTIVATION | 34 | 8.17e-01 | -0.023000 | 9.23e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 26 | 8.42e-01 | -0.022600 | 9.38e-01 |
RHO GTPASES ACTIVATE FORMINS | 119 | 6.72e-01 | 0.022500 | 8.56e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 8.63e-01 | 0.022300 | 9.43e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 8.98e-01 | -0.022200 | 9.59e-01 |
ENDOGENOUS STEROLS | 21 | 8.62e-01 | 0.022000 | 9.43e-01 |
DNA REPAIR | 292 | 5.22e-01 | 0.021800 | 7.74e-01 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 8.73e-01 | -0.021700 | 9.49e-01 |
SIGNALING BY MET | 75 | 7.47e-01 | 0.021600 | 8.92e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 92 | 7.25e-01 | -0.021300 | 8.76e-01 |
MITOTIC PROMETAPHASE | 177 | 6.27e-01 | -0.021200 | 8.28e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 8.52e-01 | 0.021100 | 9.40e-01 |
SEMAPHORIN INTERACTIONS | 64 | 7.71e-01 | 0.021100 | 9.03e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 8.95e-01 | 0.021100 | 9.58e-01 |
SIGNALING BY WNT | 270 | 5.58e-01 | 0.020800 | 7.92e-01 |
MEMBRANE TRAFFICKING | 581 | 3.99e-01 | 0.020600 | 6.91e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 8.95e-01 | 0.020400 | 9.58e-01 |
CELL CYCLE CHECKPOINTS | 242 | 5.86e-01 | 0.020300 | 8.13e-01 |
RET SIGNALING | 37 | 8.33e-01 | -0.020000 | 9.33e-01 |
PURINE CATABOLISM | 16 | 8.91e-01 | -0.019700 | 9.57e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 53 | 8.05e-01 | 0.019600 | 9.19e-01 |
HDACS DEACETYLATE HISTONES | 48 | 8.15e-01 | 0.019600 | 9.23e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 347 | 5.32e-01 | -0.019600 | 7.79e-01 |
ADAPTIVE IMMUNE SYSTEM | 601 | 4.15e-01 | -0.019500 | 6.99e-01 |
NERVOUS SYSTEM DEVELOPMENT | 550 | 4.36e-01 | 0.019500 | 7.11e-01 |
SMOOTH MUSCLE CONTRACTION | 34 | 8.45e-01 | 0.019400 | 9.39e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 8.62e-01 | -0.019400 | 9.43e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 7.03e-01 | -0.019100 | 8.65e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 46 | 8.24e-01 | -0.019000 | 9.27e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 8.39e-01 | -0.018900 | 9.37e-01 |
CELL CYCLE MITOTIC | 476 | 4.85e-01 | 0.018700 | 7.55e-01 |
PEPTIDE HORMONE METABOLISM | 61 | 8.01e-01 | -0.018600 | 9.19e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 8.92e-01 | -0.018400 | 9.57e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 8.22e-01 | -0.018300 | 9.26e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 9.13e-01 | -0.018100 | 9.65e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 8.92e-01 | 0.018100 | 9.57e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 9.04e-01 | 0.018100 | 9.62e-01 |
RAB REGULATION OF TRAFFICKING | 119 | 7.38e-01 | 0.017800 | 8.88e-01 |
G0 AND EARLY G1 | 25 | 8.78e-01 | 0.017700 | 9.52e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 7.58e-01 | 0.017600 | 8.95e-01 |
INTEGRIN SIGNALING | 24 | 8.83e-01 | -0.017400 | 9.52e-01 |
SPHINGOLIPID METABOLISM | 80 | 7.89e-01 | 0.017300 | 9.15e-01 |
SIGNALING BY PTK6 | 50 | 8.34e-01 | -0.017200 | 9.33e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 44 | 8.48e-01 | -0.016700 | 9.39e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 8.30e-01 | 0.016600 | 9.32e-01 |
PYROPTOSIS | 21 | 8.96e-01 | -0.016400 | 9.58e-01 |
INTERLEUKIN 12 SIGNALING | 37 | 8.64e-01 | 0.016300 | 9.43e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 8.65e-01 | -0.016100 | 9.43e-01 |
GENE SILENCING BY RNA | 84 | 8.02e-01 | -0.015900 | 9.19e-01 |
HEME BIOSYNTHESIS | 13 | 9.23e-01 | -0.015500 | 9.70e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 9.14e-01 | -0.015200 | 9.65e-01 |
SHC MEDIATED CASCADE FGFR4 | 12 | 9.28e-01 | 0.015100 | 9.73e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 8.80e-01 | 0.015000 | 9.52e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 340 | 6.37e-01 | -0.014900 | 8.33e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 9.20e-01 | -0.014900 | 9.68e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 8.15e-01 | 0.014700 | 9.23e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 8.95e-01 | -0.014500 | 9.58e-01 |
L1CAM INTERACTIONS | 109 | 7.98e-01 | -0.014200 | 9.19e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 8.83e-01 | -0.014200 | 9.52e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 9.15e-01 | 0.014200 | 9.65e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 39 | 8.82e-01 | 0.013700 | 9.52e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 286 | 6.92e-01 | -0.013600 | 8.63e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 8.44e-01 | -0.013500 | 9.39e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 68 | 8.51e-01 | 0.013200 | 9.39e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 65 | 8.59e-01 | -0.012700 | 9.43e-01 |
SYNTHESIS OF PC | 26 | 9.11e-01 | 0.012700 | 9.65e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 9.15e-01 | -0.012700 | 9.65e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 9.45e-01 | 0.012700 | 9.81e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 94 | 8.36e-01 | 0.012400 | 9.35e-01 |
DUAL INCISION IN GG NER | 40 | 8.97e-01 | 0.011800 | 9.58e-01 |
TRANSPORT OF SMALL MOLECULES | 583 | 6.38e-01 | -0.011400 | 8.34e-01 |
CHROMATIN MODIFYING ENZYMES | 220 | 7.74e-01 | -0.011300 | 9.04e-01 |
INNATE IMMUNE SYSTEM | 781 | 6.12e-01 | 0.010700 | 8.22e-01 |
SIGNALING BY CSF3 G CSF | 29 | 9.21e-01 | 0.010700 | 9.68e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 9.43e-01 | 0.010600 | 9.81e-01 |
REGULATED NECROSIS | 46 | 9.01e-01 | 0.010600 | 9.61e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1221 | 5.62e-01 | 0.009940 | 7.95e-01 |
SIGNALING BY INTERLEUKINS | 345 | 7.53e-01 | 0.009860 | 8.94e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 9.34e-01 | 0.009830 | 9.76e-01 |
SHC MEDIATED CASCADE FGFR1 | 15 | 9.48e-01 | 0.009690 | 9.81e-01 |
HATS ACETYLATE HISTONES | 94 | 8.71e-01 | 0.009680 | 9.48e-01 |
SIGNALING BY NOTCH1 | 75 | 8.86e-01 | -0.009590 | 9.54e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 9.37e-01 | 0.009520 | 9.78e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 9.57e-01 | -0.009430 | 9.86e-01 |
SIGNAL AMPLIFICATION | 31 | 9.28e-01 | 0.009320 | 9.73e-01 |
MITOTIC SPINDLE CHECKPOINT | 97 | 8.76e-01 | -0.009150 | 9.51e-01 |
METABOLISM OF LIPIDS | 616 | 7.04e-01 | 0.009010 | 8.65e-01 |
SENSORY PERCEPTION | 148 | 8.50e-01 | 0.009000 | 9.39e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 9.06e-01 | -0.008750 | 9.64e-01 |
RHO GTPASES ACTIVATE PKNS | 49 | 9.17e-01 | -0.008640 | 9.66e-01 |
G ALPHA S SIGNALLING EVENTS | 108 | 8.82e-01 | 0.008280 | 9.52e-01 |
ARACHIDONIC ACID METABOLISM | 38 | 9.30e-01 | -0.008200 | 9.73e-01 |
HCMV LATE EVENTS | 67 | 9.10e-01 | -0.007980 | 9.65e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 366 | 7.98e-01 | -0.007810 | 9.19e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 9.40e-01 | 0.007480 | 9.79e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 76 | 9.11e-01 | -0.007460 | 9.65e-01 |
NOD1 2 SIGNALING PATHWAY | 34 | 9.40e-01 | -0.007420 | 9.79e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 9.12e-01 | 0.007230 | 9.65e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 9.48e-01 | 0.007040 | 9.81e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 9.49e-01 | 0.006940 | 9.81e-01 |
PROLACTIN RECEPTOR SIGNALING | 11 | 9.68e-01 | -0.006930 | 9.91e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 224 | 8.65e-01 | -0.006610 | 9.43e-01 |
CARGO CONCENTRATION IN THE ER | 31 | 9.50e-01 | 0.006480 | 9.81e-01 |
CELL CYCLE | 593 | 7.93e-01 | 0.006340 | 9.17e-01 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 9.51e-01 | 0.006320 | 9.81e-01 |
SIGNALING BY FGFR3 | 35 | 9.49e-01 | -0.006200 | 9.81e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 9.61e-01 | -0.006120 | 9.89e-01 |
MTOR SIGNALLING | 40 | 9.47e-01 | 0.006040 | 9.81e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 9.30e-01 | -0.005920 | 9.73e-01 |
TRP CHANNELS | 20 | 9.64e-01 | 0.005830 | 9.89e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 9.63e-01 | -0.005740 | 9.89e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 124 | 9.12e-01 | 0.005720 | 9.65e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 29 | 9.59e-01 | 0.005550 | 9.87e-01 |
SHC MEDIATED CASCADE FGFR3 | 13 | 9.74e-01 | 0.005260 | 9.93e-01 |
RHOBTB3 ATPASE CYCLE | 10 | 9.77e-01 | 0.005170 | 9.94e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 9.75e-01 | -0.004900 | 9.93e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 9.78e-01 | 0.004800 | 9.94e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 9.42e-01 | 0.004730 | 9.81e-01 |
HIV LIFE CYCLE | 142 | 9.27e-01 | 0.004440 | 9.73e-01 |
DEUBIQUITINATION | 242 | 9.06e-01 | 0.004400 | 9.64e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 63 | 9.52e-01 | 0.004390 | 9.82e-01 |
DEVELOPMENTAL BIOLOGY | 822 | 8.40e-01 | 0.004180 | 9.37e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 9.64e-01 | 0.004120 | 9.89e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 9.81e-01 | -0.003720 | 9.94e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 9.71e-01 | -0.003650 | 9.93e-01 |
G ALPHA Q SIGNALLING EVENTS | 166 | 9.36e-01 | -0.003630 | 9.77e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 9.76e-01 | -0.003480 | 9.94e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 52 | 9.68e-01 | 0.003230 | 9.91e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 9.68e-01 | -0.003010 | 9.91e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 61 | 9.69e-01 | -0.002880 | 9.91e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 9.82e-01 | -0.002730 | 9.94e-01 |
SIGNALING BY FGFR4 | 33 | 9.79e-01 | 0.002630 | 9.94e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 9.79e-01 | -0.002370 | 9.94e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 9.85e-01 | -0.002080 | 9.96e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 11 | 9.91e-01 | 0.002030 | 9.97e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 9.89e-01 | -0.001680 | 9.97e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 9.87e-01 | -0.001600 | 9.97e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 9.90e-01 | -0.001550 | 9.97e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 9.81e-01 | -0.001490 | 9.94e-01 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 9.94e-01 | 0.001320 | 9.98e-01 |
PHASE 2 PLATEAU PHASE | 12 | 9.94e-01 | 0.001180 | 9.98e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 32 | 9.91e-01 | 0.001170 | 9.97e-01 |
GAP JUNCTION DEGRADATION | 11 | 9.95e-01 | 0.001080 | 9.98e-01 |
MAPK FAMILY SIGNALING CASCADES | 287 | 9.75e-01 | -0.001080 | 9.93e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 9.92e-01 | 0.000912 | 9.97e-01 |
REGULATION OF TP53 ACTIVITY | 149 | 9.90e-01 | 0.000574 | 9.97e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 9.98e-01 | -0.000538 | 9.98e-01 |
TRNA PROCESSING | 105 | 9.96e-01 | 0.000271 | 9.98e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 9.98e-01 | -0.000239 | 9.98e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
726 | |
---|---|
set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
setSize | 17 |
pANOVA | 7.45e-06 |
s.dist | 0.628 |
p.adjustANOVA | 0.000572 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tbcb | 7012 |
Tubb2b | 6485 |
Arl2 | 6353 |
Tuba4a | 5172 |
Tbcd | 5060 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Tbcc | 2453 |
Tbca | -1008 |
Tbce | -3125 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tbcb | 7012 |
Tubb2b | 6485 |
Arl2 | 6353 |
Tuba4a | 5172 |
Tbcd | 5060 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Tbcc | 2453 |
Tbca | -1008 |
Tbce | -3125 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
1138 | |
---|---|
set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
setSize | 13 |
pANOVA | 0.000228 |
s.dist | 0.59 |
p.adjustANOVA | 0.00596 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Gjb2 | -4211 |
Gja1 | -4294 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Gjb2 | -4211 |
Gja1 | -4294 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
337 | |
---|---|
set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
setSize | 19 |
pANOVA | 1.23e-05 |
s.dist | 0.579 |
p.adjustANOVA | 0.000725 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Cct5 | 7963 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Cct7 | 7270 |
Tubb3 | 7249 |
Cct3 | 7238 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Cct4 | 3811 |
Tuba1c | 2959 |
Cct2 | 622 |
Cct6a | -2053 |
Cct8 | -2181 |
Tcp1 | -3184 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Cct5 | 7963 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Cct7 | 7270 |
Tubb3 | 7249 |
Cct3 | 7238 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Cct4 | 3811 |
Tuba1c | 2959 |
Cct2 | 622 |
Cct6a | -2053 |
Cct8 | -2181 |
Tcp1 | -3184 |
CGMP EFFECTS
143 | |
---|---|
set | CGMP EFFECTS |
setSize | 15 |
pANOVA | 0.000152 |
s.dist | -0.565 |
p.adjustANOVA | 0.00473 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Kcnmb2 | -8593 |
Pde1b | -8173 |
Pde10a | -8110 |
Pde1a | -7947 |
Pde2a | -7423 |
Itpr1 | -7382 |
Kcnma1 | -7275 |
Pde5a | -6730 |
Prkg1 | -5079 |
Prkg2 | -4790 |
Pde11a | -3892 |
Kcnmb4 | -3824 |
Irag1 | -1232 |
Pde9a | 2599 |
Kcnmb1 | 4569 |
GeneID | Gene Rank |
---|---|
Kcnmb2 | -8593 |
Pde1b | -8173 |
Pde10a | -8110 |
Pde1a | -7947 |
Pde2a | -7423 |
Itpr1 | -7382 |
Kcnma1 | -7275 |
Pde5a | -6730 |
Prkg1 | -5079 |
Prkg2 | -4790 |
Pde11a | -3892 |
Kcnmb4 | -3824 |
Irag1 | -1232 |
Pde9a | 2599 |
Kcnmb1 | 4569 |
REDUCTION OF CYTOSOLIC CA LEVELS
785 | |
---|---|
set | REDUCTION OF CYTOSOLIC CA LEVELS |
setSize | 11 |
pANOVA | 0.00133 |
s.dist | -0.559 |
p.adjustANOVA | 0.0212 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp2b1 | -8492 |
Slc8a1 | -8192 |
Calm1 | -7912 |
Atp2b4 | -7751 |
Atp2a3 | -7140 |
Atp2b2 | -6936 |
Sri | -6775 |
Atp2a2 | -4272 |
Atp2b3 | -1357 |
Slc8a3 | 1467 |
Slc8a2 | 4174 |
GeneID | Gene Rank |
---|---|
Atp2b1 | -8492 |
Slc8a1 | -8192 |
Calm1 | -7912 |
Atp2b4 | -7751 |
Atp2a3 | -7140 |
Atp2b2 | -6936 |
Sri | -6775 |
Atp2a2 | -4272 |
Atp2b3 | -1357 |
Slc8a3 | 1467 |
Slc8a2 | 4174 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
629 | |
---|---|
set | NITRIC OXIDE STIMULATES GUANYLATE CYCLASE |
setSize | 20 |
pANOVA | 5.99e-05 |
s.dist | -0.518 |
p.adjustANOVA | 0.00221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Kcnmb2 | -8593 |
Gucy1a1 | -8551 |
Pde1b | -8173 |
Pde10a | -8110 |
Pde1a | -7947 |
Pde2a | -7423 |
Itpr1 | -7382 |
Kcnma1 | -7275 |
Gucy1b1 | -6897 |
Pde5a | -6730 |
Gucy1a2 | -5566 |
Prkg1 | -5079 |
Prkg2 | -4790 |
Pde11a | -3892 |
Kcnmb4 | -3824 |
Irag1 | -1232 |
Nos3 | 1731 |
Pde9a | 2599 |
Nos1 | 2800 |
Kcnmb1 | 4569 |
GeneID | Gene Rank |
---|---|
Kcnmb2 | -8593 |
Gucy1a1 | -8551 |
Pde1b | -8173 |
Pde10a | -8110 |
Pde1a | -7947 |
Pde2a | -7423 |
Itpr1 | -7382 |
Kcnma1 | -7275 |
Gucy1b1 | -6897 |
Pde5a | -6730 |
Gucy1a2 | -5566 |
Prkg1 | -5079 |
Prkg2 | -4790 |
Pde11a | -3892 |
Kcnmb4 | -3824 |
Irag1 | -1232 |
Nos3 | 1731 |
Pde9a | 2599 |
Nos1 | 2800 |
Kcnmb1 | 4569 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
910 | |
---|---|
set | SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III |
setSize | 23 |
pANOVA | 2.23e-05 |
s.dist | 0.511 |
p.adjustANOVA | 0.0011 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lemd2 | 8336 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Chmp4b | 7599 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Chmp7 | 6852 |
Tubb2b | 6485 |
Chmp6 | 6179 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Vps4a | 4513 |
Cc2d1b | 4243 |
Chmp2a | 3814 |
Tuba1c | 2959 |
Chmp3 | -111 |
Ist1 | -1820 |
GeneID | Gene Rank |
---|---|
Lemd2 | 8336 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Chmp4b | 7599 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Chmp7 | 6852 |
Tubb2b | 6485 |
Chmp6 | 6179 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Vps4a | 4513 |
Cc2d1b | 4243 |
Chmp2a | 3814 |
Tuba1c | 2959 |
Chmp3 | -111 |
Ist1 | -1820 |
Chmp4c | -2091 |
Spast | -3708 |
Chmp2b | -8308 |
P75NTR REGULATES AXONOGENESIS
679 | |
---|---|
set | P75NTR REGULATES AXONOGENESIS |
setSize | 10 |
pANOVA | 0.00688 |
s.dist | -0.494 |
p.adjustANOVA | 0.0659 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mcf2 | -7952 |
Rtn4 | -7632 |
Omg | -7276 |
Ngfr | -6655 |
Rtn4r | -6170 |
Ngf | -4922 |
Mag | -4626 |
Rhoa | -3097 |
Lingo1 | -2615 |
Arhgdia | 8150 |
GeneID | Gene Rank |
---|---|
Mcf2 | -7952 |
Rtn4 | -7632 |
Omg | -7276 |
Ngfr | -6655 |
Rtn4r | -6170 |
Ngf | -4922 |
Mag | -4626 |
Rhoa | -3097 |
Lingo1 | -2615 |
Arhgdia | 8150 |
APOPTOSIS INDUCED DNA FRAGMENTATION
66 | |
---|---|
set | APOPTOSIS INDUCED DNA FRAGMENTATION |
setSize | 10 |
pANOVA | 0.0091 |
s.dist | -0.476 |
p.adjustANOVA | 0.0801 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H1f2 | -8585 |
H1f0 | -8564 |
Hmgb1 | -7098 |
Kpna1 | -6304 |
Hmgb2 | -5785 |
H1f4 | -2606 |
Casp3 | -2347 |
Kpnb1 | -1912 |
Dffb | -1325 |
Dffa | 3203 |
GeneID | Gene Rank |
---|---|
H1f2 | -8585 |
H1f0 | -8564 |
Hmgb1 | -7098 |
Kpna1 | -6304 |
Hmgb2 | -5785 |
H1f4 | -2606 |
Casp3 | -2347 |
Kpnb1 | -1912 |
Dffb | -1325 |
Dffa | 3203 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
1173 | |
---|---|
set | WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 |
setSize | 13 |
pANOVA | 0.00337 |
s.dist | 0.47 |
p.adjustANOVA | 0.0402 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fzd2 | 7851 |
Cltb | 7638 |
Clta | 6913 |
Ap2a1 | 6686 |
Ap2s1 | 6398 |
Fzd5 | 6237 |
Ap2m1 | 6090 |
Ap2a2 | 4317 |
Ror1 | 2872 |
Wnt5a | 2566 |
Ror2 | 928 |
Ap2b1 | -2190 |
Cltc | -5096 |
GeneID | Gene Rank |
---|---|
Fzd2 | 7851 |
Cltb | 7638 |
Clta | 6913 |
Ap2a1 | 6686 |
Ap2s1 | 6398 |
Fzd5 | 6237 |
Ap2m1 | 6090 |
Ap2a2 | 4317 |
Ror1 | 2872 |
Wnt5a | 2566 |
Ror2 | 928 |
Ap2b1 | -2190 |
Cltc | -5096 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION
161 | |
---|---|
set | CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION |
setSize | 11 |
pANOVA | 0.0108 |
s.dist | -0.444 |
p.adjustANOVA | 0.0912 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp3r1 | -8475 |
Ahcyl1 | -8415 |
Ppp3ca | -8382 |
Calm1 | -7912 |
Ppp3cb | -7899 |
Nfatc3 | -7646 |
Itpr1 | -7382 |
Nfatc1 | 247 |
Itpr2 | 3158 |
Itpr3 | 4749 |
Nfatc2 | 5553 |
GeneID | Gene Rank |
---|---|
Ppp3r1 | -8475 |
Ahcyl1 | -8415 |
Ppp3ca | -8382 |
Calm1 | -7912 |
Ppp3cb | -7899 |
Nfatc3 | -7646 |
Itpr1 | -7382 |
Nfatc1 | 247 |
Itpr2 | 3158 |
Itpr3 | 4749 |
Nfatc2 | 5553 |
GAP JUNCTION ASSEMBLY
368 | |
---|---|
set | GAP JUNCTION ASSEMBLY |
setSize | 21 |
pANOVA | 0.000568 |
s.dist | 0.434 |
p.adjustANOVA | 0.0112 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Gja4 | 7674 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Gjb6 | 5880 |
Gjd3 | 5295 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Gja5 | 2828 |
Gjb1 | -810 |
Gjc2 | -1109 |
Gjd2 | -3852 |
Gjc1 | -4127 |
Gjb2 | -4211 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Gja4 | 7674 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Gjb6 | 5880 |
Gjd3 | 5295 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Gja5 | 2828 |
Gjb1 | -810 |
Gjc2 | -1109 |
Gjd2 | -3852 |
Gjc1 | -4127 |
Gjb2 | -4211 |
Gja1 | -4294 |
IRE1ALPHA ACTIVATES CHAPERONES
498 | |
---|---|
set | IRE1ALPHA ACTIVATES CHAPERONES |
setSize | 50 |
pANOVA | 4.02e-07 |
s.dist | 0.414 |
p.adjustANOVA | 7.94e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Preb | 8329 |
Pdia6 | 8314 |
Lmna | 8036 |
Cxxc1 | 7993 |
Cul7 | 7974 |
Tln1 | 7828 |
Dnajb11 | 7757 |
Hdgf | 7584 |
Hspa5 | 7487 |
Xbp1 | 7281 |
Mydgf | 7186 |
Klhdc3 | 7144 |
Syvn1 | 7133 |
Dctn1 | 7081 |
Yif1a | 6754 |
Srpr | 6547 |
Acadvl | 6284 |
Gosr2 | 6071 |
Tspyl2 | 6056 |
Hyou1 | 6018 |
GeneID | Gene Rank |
---|---|
Preb | 8329 |
Pdia6 | 8314 |
Lmna | 8036 |
Cxxc1 | 7993 |
Cul7 | 7974 |
Tln1 | 7828 |
Dnajb11 | 7757 |
Hdgf | 7584 |
Hspa5 | 7487 |
Xbp1 | 7281 |
Mydgf | 7186 |
Klhdc3 | 7144 |
Syvn1 | 7133 |
Dctn1 | 7081 |
Yif1a | 6754 |
Srpr | 6547 |
Acadvl | 6284 |
Gosr2 | 6071 |
Tspyl2 | 6056 |
Hyou1 | 6018 |
Arfgap1 | 5801 |
Srprb | 5762 |
Pla2g4b | 5672 |
Tpp1 | 5630 |
Gsk3a | 5491 |
Add1 | 5429 |
Dnajc3 | 5337 |
Ppp2r5b | 5276 |
Sult1a1 | 4613 |
Ddx11 | 4331 |
Kdelr3 | 4252 |
Fkbp14 | 4231 |
Pdia5 | 3992 |
Zbtb17 | 3511 |
Shc1 | 2907 |
Atp6v0d1 | 2713 |
Extl3 | 2532 |
Tatdn2 | 806 |
Sec31a | -1308 |
Ern1 | -1516 |
Wipi1 | -2072 |
Ctdsp2 | -2708 |
Gfpt1 | -3689 |
Serp1 | -4396 |
Ssr1 | -4536 |
Extl1 | -4804 |
Wfs1 | -4910 |
Edem1 | -5332 |
Dnajb9 | -6985 |
Extl2 | -7902 |
GLYCOGEN STORAGE DISEASES
388 | |
---|---|
set | GLYCOGEN STORAGE DISEASES |
setSize | 12 |
pANOVA | 0.0142 |
s.dist | 0.409 |
p.adjustANOVA | 0.107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gaa | 7838 |
Ubb | 7291 |
G6pc3 | 6828 |
Nhlrc1 | 5452 |
Uba52 | 4626 |
Gys1 | 4196 |
Gbe1 | 4072 |
Ppp1r3c | 3895 |
Ubc | 2638 |
Rps27a | 2557 |
Gyg | -1664 |
Epm2a | -6696 |
GeneID | Gene Rank |
---|---|
Gaa | 7838 |
Ubb | 7291 |
G6pc3 | 6828 |
Nhlrc1 | 5452 |
Uba52 | 4626 |
Gys1 | 4196 |
Gbe1 | 4072 |
Ppp1r3c | 3895 |
Ubc | 2638 |
Rps27a | 2557 |
Gyg | -1664 |
Epm2a | -6696 |
VOLTAGE GATED POTASSIUM CHANNELS
1170 | |
---|---|
set | VOLTAGE GATED POTASSIUM CHANNELS |
setSize | 39 |
pANOVA | 1.43e-05 |
s.dist | -0.402 |
p.adjustANOVA | 0.000801 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Kcna2 | -8534 |
Kcnh7 | -8521 |
Kcns1 | -8390 |
Kcnab1 | -8331 |
Kcnq5 | -7987 |
Kcnv1 | -7975 |
Kcnq3 | -7831 |
Kcng1 | -7727 |
Kcnab3 | -7681 |
Kcnc2 | -7529 |
Kcnd3 | -7437 |
Kcnq1 | -7284 |
Kcnd2 | -6981 |
Kcnh3 | -6966 |
Kcna1 | -6288 |
Kcnb2 | -5927 |
Kcnh5 | -5308 |
Kcna4 | -5274 |
Kcnf1 | -4994 |
Kcns2 | -4936 |
GeneID | Gene Rank |
---|---|
Kcna2 | -8534 |
Kcnh7 | -8521 |
Kcns1 | -8390 |
Kcnab1 | -8331 |
Kcnq5 | -7987 |
Kcnv1 | -7975 |
Kcnq3 | -7831 |
Kcng1 | -7727 |
Kcnab3 | -7681 |
Kcnc2 | -7529 |
Kcnd3 | -7437 |
Kcnq1 | -7284 |
Kcnd2 | -6981 |
Kcnh3 | -6966 |
Kcna1 | -6288 |
Kcnb2 | -5927 |
Kcnh5 | -5308 |
Kcna4 | -5274 |
Kcnf1 | -4994 |
Kcns2 | -4936 |
Kcnd1 | -4859 |
Kcna6 | -3962 |
Kcnb1 | -3808 |
Kcnh1 | -2683 |
Kcng4 | -2539 |
Kcnc1 | -2105 |
Kcnq2 | -2013 |
Kcnh4 | -1512 |
Kcna3 | -581 |
Kcnab2 | -430 |
Kcnh8 | 106 |
Kcna5 | 808 |
Kcnc3 | 1718 |
Kcnq4 | 2725 |
Kcnh2 | 3382 |
Kcng2 | 3987 |
Kcnc4 | 4379 |
Kcnh6 | 5744 |
Kcns3 | 7485 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
112 | |
---|---|
set | CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN |
setSize | 36 |
pANOVA | 4.16e-05 |
s.dist | 0.395 |
p.adjustANOVA | 0.00182 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Ttll10 | 7533 |
Tubb6 | 7443 |
Ttll8 | 7378 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Ttll12 | 6621 |
Tpgs1 | 6530 |
Tubb2b | 6485 |
Ttll11 | 6316 |
Ttll9 | 6159 |
Tuba4a | 5172 |
Ttll1 | 4954 |
Tuba8 | 4754 |
Agbl5 | 4476 |
Agbl2 | 4071 |
Ttll6 | 3546 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Ttll10 | 7533 |
Tubb6 | 7443 |
Ttll8 | 7378 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Ttll12 | 6621 |
Tpgs1 | 6530 |
Tubb2b | 6485 |
Ttll11 | 6316 |
Ttll9 | 6159 |
Tuba4a | 5172 |
Ttll1 | 4954 |
Tuba8 | 4754 |
Agbl5 | 4476 |
Agbl2 | 4071 |
Ttll6 | 3546 |
Svbp | 3375 |
Ttll4 | 3170 |
Ttl | 3165 |
Tuba1c | 2959 |
Nicn1 | 2660 |
Agbl4 | 2628 |
Ttll5 | 1136 |
Lrrc49 | 494 |
Ttll3 | 337 |
Vash1 | -200 |
Ttll13 | -1624 |
Tpgs2 | -3177 |
Agbl3 | -3647 |
Vash2 | -4267 |
Agtpbp1 | -7631 |
Ttll7 | -8473 |
AGGREPHAGY
43 | |
---|---|
set | AGGREPHAGY |
setSize | 35 |
pANOVA | 5.81e-05 |
s.dist | 0.393 |
p.adjustANOVA | 0.00221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsf1 | 8293 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Vim | 7567 |
Tubb6 | 7443 |
Ubb | 7291 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Dync1i1 | 6412 |
Vcp | 6085 |
Ift88 | 5601 |
Hdac6 | 5424 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Park7 | 4660 |
Uba52 | 4626 |
Dynll2 | 4069 |
GeneID | Gene Rank |
---|---|
Hsf1 | 8293 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Vim | 7567 |
Tubb6 | 7443 |
Ubb | 7291 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Dync1i1 | 6412 |
Vcp | 6085 |
Ift88 | 5601 |
Hdac6 | 5424 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Park7 | 4660 |
Uba52 | 4626 |
Dynll2 | 4069 |
Ube2v1 | 3672 |
Tuba1c | 2959 |
Ubc | 2638 |
Rps27a | 2557 |
Dync1h1 | 2365 |
Dync1li1 | 2253 |
Dynll1 | 2070 |
Prkn | -1435 |
Cftr | -2284 |
Pcnt | -3562 |
Arl13b | -3569 |
Dync1i2 | -4031 |
Dync1li2 | -4381 |
Ube2n | -7118 |
Hsp90aa1 | -7565 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
1072 | |
---|---|
set | THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT |
setSize | 66 |
pANOVA | 5.45e-08 |
s.dist | 0.387 |
p.adjustANOVA | 2.14e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Psmd3 | 8001 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Psmb5 | 7501 |
Tubb6 | 7443 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Tubb2b | 6485 |
Psmb6 | 6408 |
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Psmd3 | 8001 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Psmb5 | 7501 |
Tubb6 | 7443 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Tubb2b | 6485 |
Psmb6 | 6408 |
Plk1 | 6346 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Tuba4a | 5172 |
Psmb10 | 4883 |
Psmc2 | 4874 |
Tuba8 | 4754 |
Uba52 | 4626 |
Psmb7 | 4582 |
Psmb1 | 4506 |
Psmd2 | 4249 |
Psma2 | 4186 |
Ccnb2 | 4120 |
Psma7 | 4046 |
Psmb3 | 3606 |
Psmd9 | 3385 |
Tuba1c | 2959 |
Ubc | 2638 |
Rps27a | 2557 |
Psma6 | 2335 |
Psmd6 | 2277 |
Cdkn1a | 2186 |
Hsp90ab1 | 2018 |
Psmd5 | 1752 |
Psmd1 | 1242 |
Trp53 | 1200 |
Psmd14 | 138 |
Psme3 | -87 |
Psma4 | -131 |
Psma1 | -846 |
Psmf1 | -1102 |
Psma3 | -1208 |
Psmd11 | -2344 |
Psmc1 | -2685 |
Fkbpl | -3834 |
Psmd12 | -4537 |
Psmc6 | -5059 |
Mapre1 | -5375 |
Psme4 | -5592 |
Psmb8 | -6856 |
Psmb9 | -7446 |
Hsp90aa1 | -7565 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
201 | |
---|---|
set | CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY |
setSize | 13 |
pANOVA | 0.0163 |
s.dist | 0.385 |
p.adjustANOVA | 0.116 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ciapin1 | 8111 |
Nubp1 | 7783 |
Ercc2 | 6866 |
Ciao1 | 6819 |
Pold1 | 5251 |
Brip1 | 4583 |
Ciao3 | 4562 |
Nubp2 | 3984 |
Mms19 | 3403 |
Ciao2b | 2776 |
Rtel1 | 239 |
Ndor1 | -5214 |
Abcb7 | -7377 |
GeneID | Gene Rank |
---|---|
Ciapin1 | 8111 |
Nubp1 | 7783 |
Ercc2 | 6866 |
Ciao1 | 6819 |
Pold1 | 5251 |
Brip1 | 4583 |
Ciao3 | 4562 |
Nubp2 | 3984 |
Mms19 | 3403 |
Ciao2b | 2776 |
Rtel1 | 239 |
Ndor1 | -5214 |
Abcb7 | -7377 |
SODIUM CALCIUM EXCHANGERS
1006 | |
---|---|
set | SODIUM CALCIUM EXCHANGERS |
setSize | 10 |
pANOVA | 0.0353 |
s.dist | -0.384 |
p.adjustANOVA | 0.196 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc24a2 | -8535 |
Slc8a1 | -8192 |
Calm1 | -7912 |
Sri | -6775 |
Slc8b1 | -2408 |
Slc24a3 | -2134 |
Slc24a5 | -1806 |
Slc24a4 | -1359 |
Slc8a3 | 1467 |
Slc8a2 | 4174 |
GeneID | Gene Rank |
---|---|
Slc24a2 | -8535 |
Slc8a1 | -8192 |
Calm1 | -7912 |
Sri | -6775 |
Slc8b1 | -2408 |
Slc24a3 | -2134 |
Slc24a5 | -1806 |
Slc24a4 | -1359 |
Slc8a3 | 1467 |
Slc8a2 | 4174 |
INTRAFLAGELLAR TRANSPORT
487 | |
---|---|
set | INTRAFLAGELLAR TRANSPORT |
setSize | 51 |
pANOVA | 2.07e-06 |
s.dist | 0.384 |
p.adjustANOVA | 0.000244 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dynlrb2 | 8377 |
Ift122 | 8095 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Ift22 | 7913 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Dync2i2 | 7841 |
Ift46 | 7683 |
Ift172 | 7486 |
Tubb6 | 7443 |
Kif17 | 7328 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Ift74 | 7213 |
Ift43 | 7004 |
Tubb2b | 6485 |
Dynlt5 | 5659 |
Ift88 | 5601 |
Ift57 | 5352 |
GeneID | Gene Rank |
---|---|
Dynlrb2 | 8377 |
Ift122 | 8095 |
Tubb4b | 8034 |
Tubb2a | 8027 |
Ift22 | 7913 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Dync2i2 | 7841 |
Ift46 | 7683 |
Ift172 | 7486 |
Tubb6 | 7443 |
Kif17 | 7328 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Ift74 | 7213 |
Ift43 | 7004 |
Tubb2b | 6485 |
Dynlt5 | 5659 |
Ift88 | 5601 |
Ift57 | 5352 |
Tuba4a | 5172 |
Ift140 | 4868 |
Dync2i1 | 4816 |
Ift52 | 4497 |
Ift27 | 4198 |
Dynll2 | 4069 |
Wdr35 | 3960 |
Tuba1c | 2959 |
Dync2li1 | 2495 |
Dynll1 | 2070 |
Ttc30b | 1747 |
Kif3c | 1727 |
Dync2h1 | 1545 |
Dynlrb1 | 1247 |
Dynlt2a2 | 1141 |
Hspb11 | 569 |
Traf3ip1 | 437 |
Cluap1 | 383 |
Ift20 | 265 |
Kif3a | 188 |
Ttc30a1 | -328 |
Kif3b | -349 |
Ift80 | -814 |
Ift81 | -1254 |
Ttc21b | -1648 |
Dynlt2b | -1872 |
Trip11 | -2698 |
Wdr19 | -3581 |
Kifap3 | -5578 |
Tnpo1 | -6035 |
Ttc26 | -6595 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
180 | |
---|---|
set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
setSize | 26 |
pANOVA | 0.000727 |
s.dist | 0.383 |
p.adjustANOVA | 0.0132 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Cct5 | 7963 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Cct7 | 7270 |
Tubb3 | 7249 |
Cct3 | 7238 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Pfdn1 | 4143 |
Pfdn6 | 3892 |
Cct4 | 3811 |
Tuba1c | 2959 |
Pfdn5 | 1704 |
Pfdn2 | 869 |
Cct2 | 622 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Cct5 | 7963 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Cct7 | 7270 |
Tubb3 | 7249 |
Cct3 | 7238 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Tuba4a | 5172 |
Tuba8 | 4754 |
Pfdn1 | 4143 |
Pfdn6 | 3892 |
Cct4 | 3811 |
Tuba1c | 2959 |
Pfdn5 | 1704 |
Pfdn2 | 869 |
Cct2 | 622 |
Cct6a | -2053 |
Cct8 | -2181 |
Tcp1 | -3184 |
Pfdn4 | -6239 |
Vbp1 | -6477 |
Actb | -7374 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
187 | |
---|---|
set | CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE |
setSize | 11 |
pANOVA | 0.0281 |
s.dist | -0.382 |
p.adjustANOVA | 0.165 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy1 | -8407 |
Prkar2b | -7923 |
Calm1 | -7912 |
Prkx | -6770 |
Adcy8 | -6521 |
Creb1 | -4279 |
Prkacb | -3508 |
Prkar1a | -2084 |
Prkar2a | -149 |
Prkaca | 5428 |
Prkar1b | 5498 |
GeneID | Gene Rank |
---|---|
Adcy1 | -8407 |
Prkar2b | -7923 |
Calm1 | -7912 |
Prkx | -6770 |
Adcy8 | -6521 |
Creb1 | -4279 |
Prkacb | -3508 |
Prkar1a | -2084 |
Prkar2a | -149 |
Prkaca | 5428 |
Prkar1b | 5498 |
XENOBIOTICS
1175 | |
---|---|
set | XENOBIOTICS |
setSize | 10 |
pANOVA | 0.0378 |
s.dist | -0.379 |
p.adjustANOVA | 0.207 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ahr | -8085 |
Ahrr | -6672 |
Cyp2j9 | -6030 |
Cyp3a13 | -5416 |
Cyp2d22 | -4560 |
Cyp2a5 | -4549 |
Arnt2 | -3120 |
Cyp2s1 | -2149 |
Arnt | 1264 |
Cyp2f2 | 6271 |
GeneID | Gene Rank |
---|---|
Ahr | -8085 |
Ahrr | -6672 |
Cyp2j9 | -6030 |
Cyp3a13 | -5416 |
Cyp2d22 | -4560 |
Cyp2a5 | -4549 |
Arnt2 | -3120 |
Cyp2s1 | -2149 |
Arnt | 1264 |
Cyp2f2 | 6271 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
299 | |
---|---|
set | ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K |
setSize | 11 |
pANOVA | 0.0296 |
s.dist | -0.379 |
p.adjustANOVA | 0.172 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Lyn | -6788 |
Pik3r1 | -6574 |
Gab1 | -6536 |
Pik3cb | -6050 |
Epor | -5010 |
Pik3r5 | -3904 |
Irs2 | -336 |
Jak2 | 1449 |
Pik3cd | 1887 |
Pik3cg | 3335 |
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Lyn | -6788 |
Pik3r1 | -6574 |
Gab1 | -6536 |
Pik3cb | -6050 |
Epor | -5010 |
Pik3r5 | -3904 |
Irs2 | -336 |
Jak2 | 1449 |
Pik3cd | 1887 |
Pik3cg | 3335 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS
620 | |
---|---|
set | NEUROTOXICITY OF CLOSTRIDIUM TOXINS |
setSize | 10 |
pANOVA | 0.0386 |
s.dist | -0.378 |
p.adjustANOVA | 0.209 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Syt1 | -8595 |
Snap25 | -8545 |
Sv2b | -8125 |
Syt2 | -7602 |
Sv2c | -3797 |
Vamp2 | -3525 |
Vamp1 | -1068 |
Stx1b | 405 |
Sv2a | 634 |
Stx1a | 7298 |
GeneID | Gene Rank |
---|---|
Syt1 | -8595 |
Snap25 | -8545 |
Sv2b | -8125 |
Syt2 | -7602 |
Sv2c | -3797 |
Vamp2 | -3525 |
Vamp1 | -1068 |
Stx1b | 405 |
Sv2a | 634 |
Stx1a | 7298 |
SIGNALING BY FGFR4 IN DISEASE
957 | |
---|---|
set | SIGNALING BY FGFR4 IN DISEASE |
setSize | 10 |
pANOVA | 0.0395 |
s.dist | -0.376 |
p.adjustANOVA | 0.212 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Frs2 | -7121 |
Kras | -6899 |
Pik3r1 | -6574 |
Nras | -6568 |
Gab1 | -6536 |
Sos1 | -4005 |
Grb2 | 2781 |
Plcg1 | 3725 |
Hras | 6195 |
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Frs2 | -7121 |
Kras | -6899 |
Pik3r1 | -6574 |
Nras | -6568 |
Gab1 | -6536 |
Sos1 | -4005 |
Grb2 | 2781 |
Plcg1 | 3725 |
Hras | 6195 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
261 | |
---|---|
set | DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY |
setSize | 23 |
pANOVA | 0.00196 |
s.dist | -0.373 |
p.adjustANOVA | 0.0285 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ube2d1 | -8286 |
Trim33 | -7841 |
Smad3 | -7792 |
Ncor1 | -7616 |
Skil | -7605 |
Nedd4l | -7590 |
Ube2d3 | -6916 |
Usp9x | -6020 |
Smurf2 | -5447 |
Rnf111 | -5382 |
Parp1 | -5188 |
Ski | -4982 |
Tgif1 | -4544 |
Tgif2 | -4233 |
Smad2 | -2411 |
Ppm1a | -2189 |
Smad4 | -2152 |
Hdac1 | -599 |
Rps27a | 2557 |
Ubc | 2638 |
GeneID | Gene Rank |
---|---|
Ube2d1 | -8286 |
Trim33 | -7841 |
Smad3 | -7792 |
Ncor1 | -7616 |
Skil | -7605 |
Nedd4l | -7590 |
Ube2d3 | -6916 |
Usp9x | -6020 |
Smurf2 | -5447 |
Rnf111 | -5382 |
Parp1 | -5188 |
Ski | -4982 |
Tgif1 | -4544 |
Tgif2 | -4233 |
Smad2 | -2411 |
Ppm1a | -2189 |
Smad4 | -2152 |
Hdac1 | -599 |
Rps27a | 2557 |
Ubc | 2638 |
Uba52 | 4626 |
Ncor2 | 4981 |
Ubb | 7291 |
MET ACTIVATES RAP1 AND RAC1
539 | |
---|---|
set | MET ACTIVATES RAP1 AND RAC1 |
setSize | 10 |
pANOVA | 0.0422 |
s.dist | -0.371 |
p.adjustANOVA | 0.221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rap1a | -7384 |
Gab1 | -6536 |
Rap1b | -6062 |
Crkl | -5154 |
Dock7 | -4612 |
Met | -4269 |
Rac1 | -3379 |
Crk | -2188 |
Grb2 | 2781 |
Rapgef1 | 4472 |
GeneID | Gene Rank |
---|---|
Rap1a | -7384 |
Gab1 | -6536 |
Rap1b | -6062 |
Crkl | -5154 |
Dock7 | -4612 |
Met | -4269 |
Rac1 | -3379 |
Crk | -2188 |
Grb2 | 2781 |
Rapgef1 | 4472 |
RHO GTPASES ACTIVATE WASPS AND WAVES
856 | |
---|---|
set | RHO GTPASES ACTIVATE WASPS AND WAVES |
setSize | 36 |
pANOVA | 0.000123 |
s.dist | -0.37 |
p.adjustANOVA | 0.00393 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Abi2 | -8465 |
Actr2 | -8434 |
Mapk1 | -8349 |
Abi1 | -7871 |
Actr3 | -7730 |
Actb | -7374 |
Wasf1 | -7304 |
Wipf3 | -7250 |
Btk | -7040 |
Cdc42 | -6993 |
Nckap1 | -6586 |
Ptk2 | -6375 |
Nckap1l | -5891 |
Was | -5535 |
Wipf2 | -5179 |
Wasl | -5088 |
Cyfip2 | -4766 |
Brk1 | -3524 |
Rac1 | -3379 |
Wasf2 | -3289 |
GeneID | Gene Rank |
---|---|
Abi2 | -8465 |
Actr2 | -8434 |
Mapk1 | -8349 |
Abi1 | -7871 |
Actr3 | -7730 |
Actb | -7374 |
Wasf1 | -7304 |
Wipf3 | -7250 |
Btk | -7040 |
Cdc42 | -6993 |
Nckap1 | -6586 |
Ptk2 | -6375 |
Nckap1l | -5891 |
Was | -5535 |
Wipf2 | -5179 |
Wasl | -5088 |
Cyfip2 | -4766 |
Brk1 | -3524 |
Rac1 | -3379 |
Wasf2 | -3289 |
Wipf1 | -3284 |
Baiap2 | -3155 |
Actg1 | -2768 |
Nck1 | -2695 |
Wasf3 | -2391 |
Abl1 | -1987 |
Cyfip1 | -1694 |
Arpc2 | -1127 |
Arpc5 | -893 |
Arpc3 | 1525 |
Arpc4 | 2183 |
Grb2 | 2781 |
Arpc1a | 4633 |
Mapk3 | 4683 |
Arpc1b | 6550 |
Nckipsd | 8190 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2
218 | |
---|---|
set | DEFECTIVE EXT2 CAUSES EXOSTOSES 2 |
setSize | 14 |
pANOVA | 0.0204 |
s.dist | 0.358 |
p.adjustANOVA | 0.134 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sdc4 | 8044 |
Gpc4 | 6965 |
Gpc6 | 5972 |
Sdc1 | 5862 |
Ext2 | 4901 |
Sdc3 | 4492 |
Gpc2 | 4257 |
Gpc3 | 3130 |
Gpc1 | 2034 |
Agrn | 2011 |
Gpc5 | -16 |
Ext1 | -1270 |
Hspg2 | -1372 |
Sdc2 | -3214 |
GeneID | Gene Rank |
---|---|
Sdc4 | 8044 |
Gpc4 | 6965 |
Gpc6 | 5972 |
Sdc1 | 5862 |
Ext2 | 4901 |
Sdc3 | 4492 |
Gpc2 | 4257 |
Gpc3 | 3130 |
Gpc1 | 2034 |
Agrn | 2011 |
Gpc5 | -16 |
Ext1 | -1270 |
Hspg2 | -1372 |
Sdc2 | -3214 |
HDR THROUGH MMEJ ALT NHEJ
410 | |
---|---|
set | HDR THROUGH MMEJ ALT NHEJ |
setSize | 10 |
pANOVA | 0.0503 |
s.dist | -0.357 |
p.adjustANOVA | 0.235 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rad50 | -8476 |
Rbbp8 | -6168 |
Nbn | -5731 |
Parp1 | -5188 |
Parp2 | -4002 |
Polq | -3570 |
Mre11a | -2950 |
Lig3 | -2794 |
Fen1 | 414 |
Xrcc1 | 7289 |
GeneID | Gene Rank |
---|---|
Rad50 | -8476 |
Rbbp8 | -6168 |
Nbn | -5731 |
Parp1 | -5188 |
Parp2 | -4002 |
Polq | -3570 |
Mre11a | -2950 |
Lig3 | -2794 |
Fen1 | 414 |
Xrcc1 | 7289 |
PI3K EVENTS IN ERBB2 SIGNALING
706 | |
---|---|
set | PI3K EVENTS IN ERBB2 SIGNALING |
setSize | 15 |
pANOVA | 0.0173 |
s.dist | -0.355 |
p.adjustANOVA | 0.118 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nrg1 | -8488 |
Nrg3 | -7905 |
Pik3ca | -7766 |
Erbb4 | -7701 |
Egfr | -7101 |
Pik3r1 | -6574 |
Gab1 | -6536 |
Erbb3 | -6352 |
Egf | -5322 |
Hbegf | -556 |
Btc | -192 |
Grb2 | 2781 |
Nrg4 | 3770 |
Erbb2 | 4211 |
Nrg2 | 7310 |
GeneID | Gene Rank |
---|---|
Nrg1 | -8488 |
Nrg3 | -7905 |
Pik3ca | -7766 |
Erbb4 | -7701 |
Egfr | -7101 |
Pik3r1 | -6574 |
Gab1 | -6536 |
Erbb3 | -6352 |
Egf | -5322 |
Hbegf | -556 |
Btc | -192 |
Grb2 | 2781 |
Nrg4 | 3770 |
Erbb2 | 4211 |
Nrg2 | 7310 |
CYTOSOLIC TRNA AMINOACYLATION
204 | |
---|---|
set | CYTOSOLIC TRNA AMINOACYLATION |
setSize | 24 |
pANOVA | 0.00302 |
s.dist | 0.35 |
p.adjustANOVA | 0.0379 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mars1 | 7865 |
Vars | 6803 |
Cars | 6710 |
Farsa | 6315 |
Yars | 6286 |
Aimp2 | 6269 |
Tars | 6075 |
Qars | 5876 |
Wars | 5829 |
Ppa1 | 5203 |
Farsb | 5156 |
Eef1e1 | 5066 |
Aimp1 | 4797 |
Aars | 4584 |
Hars | 4531 |
Kars | 2987 |
Gars | 2562 |
Sars | 1058 |
Rars | -12 |
Nars | -1271 |
GeneID | Gene Rank |
---|---|
Mars1 | 7865 |
Vars | 6803 |
Cars | 6710 |
Farsa | 6315 |
Yars | 6286 |
Aimp2 | 6269 |
Tars | 6075 |
Qars | 5876 |
Wars | 5829 |
Ppa1 | 5203 |
Farsb | 5156 |
Eef1e1 | 5066 |
Aimp1 | 4797 |
Aars | 4584 |
Hars | 4531 |
Kars | 2987 |
Gars | 2562 |
Sars | 1058 |
Rars | -12 |
Nars | -1271 |
Iars | -1523 |
Dars | -6612 |
Lars | -6748 |
Eprs | -7848 |
COHESIN LOADING ONTO CHROMATIN
164 | |
---|---|
set | COHESIN LOADING ONTO CHROMATIN |
setSize | 10 |
pANOVA | 0.0555 |
s.dist | -0.35 |
p.adjustANOVA | 0.251 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Stag1 | -7027 |
Rad21 | -6527 |
Stag2 | -6043 |
Smc3 | -5230 |
Wapl | -3899 |
Pds5b | -3721 |
Pds5a | -2926 |
Nipbl | -1784 |
Smc1a | 1102 |
Mau2 | 5540 |
GeneID | Gene Rank |
---|---|
Stag1 | -7027 |
Rad21 | -6527 |
Stag2 | -6043 |
Smc3 | -5230 |
Wapl | -3899 |
Pds5b | -3721 |
Pds5a | -2926 |
Nipbl | -1784 |
Smc1a | 1102 |
Mau2 | 5540 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
804 | |
---|---|
set | REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA |
setSize | 13 |
pANOVA | 0.0302 |
s.dist | 0.347 |
p.adjustANOVA | 0.175 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ddx41 | 7495 |
Ubb | 7291 |
Irf3 | 6387 |
Uba52 | 4626 |
Trim56 | 4109 |
Dtx4 | 3978 |
Tbk1 | 2841 |
Ubc | 2638 |
Rps27a | 2557 |
Trex1 | 1736 |
Trim32 | 585 |
Sting1 | -1330 |
Trim21 | -5288 |
GeneID | Gene Rank |
---|---|
Ddx41 | 7495 |
Ubb | 7291 |
Irf3 | 6387 |
Uba52 | 4626 |
Trim56 | 4109 |
Dtx4 | 3978 |
Tbk1 | 2841 |
Ubc | 2638 |
Rps27a | 2557 |
Trex1 | 1736 |
Trim32 | 585 |
Sting1 | -1330 |
Trim21 | -5288 |
MATURATION OF NUCLEOPROTEIN
531 | |
---|---|
set | MATURATION OF NUCLEOPROTEIN |
setSize | 10 |
pANOVA | 0.0586 |
s.dist | -0.345 |
p.adjustANOVA | 0.263 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Parp14 | -8525 |
Gsk3b | -7577 |
Parp6 | -4689 |
Sumo1 | -4062 |
Parp4 | -3933 |
Parp9 | -3071 |
Parp16 | -1439 |
Ube2i | -1106 |
Parp8 | 14 |
Parp10 | 4239 |
GeneID | Gene Rank |
---|---|
Parp14 | -8525 |
Gsk3b | -7577 |
Parp6 | -4689 |
Sumo1 | -4062 |
Parp4 | -3933 |
Parp9 | -3071 |
Parp16 | -1439 |
Ube2i | -1106 |
Parp8 | 14 |
Parp10 | 4239 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
815 | |
---|---|
set | REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX |
setSize | 15 |
pANOVA | 0.0217 |
s.dist | -0.342 |
p.adjustANOVA | 0.138 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dld | -7298 |
Pdk3 | -6979 |
Pdk4 | -6754 |
Pdha1 | -6200 |
Pdpr | -6084 |
Pdp2 | -5237 |
Pdhx | -4882 |
Dlat | -4824 |
Pdp1 | -4714 |
Pdk1 | -1947 |
Pdk2 | -1880 |
Pdhb | -1160 |
Gstz1 | 1771 |
Ppard | 4962 |
Rxra | 6407 |
GeneID | Gene Rank |
---|---|
Dld | -7298 |
Pdk3 | -6979 |
Pdk4 | -6754 |
Pdha1 | -6200 |
Pdpr | -6084 |
Pdp2 | -5237 |
Pdhx | -4882 |
Dlat | -4824 |
Pdp1 | -4714 |
Pdk1 | -1947 |
Pdk2 | -1880 |
Pdhb | -1160 |
Gstz1 | 1771 |
Ppard | 4962 |
Rxra | 6407 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
15 | |
---|---|
set | ACTIVATION OF AMPK DOWNSTREAM OF NMDARS |
setSize | 20 |
pANOVA | 0.00881 |
s.dist | 0.338 |
p.adjustANOVA | 0.0786 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Mapt | 5513 |
Tuba4a | 5172 |
Prkag1 | 4832 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Prkab1 | 1684 |
Prkag2 | 149 |
Camkk2 | -3989 |
Prkab2 | -4187 |
Prkaa1 | -5555 |
Prkaa2 | -7286 |
Calm1 | -7912 |
GeneID | Gene Rank |
---|---|
Tubb4b | 8034 |
Tubb2a | 8027 |
Tuba1a | 7897 |
Tuba1b | 7879 |
Tubb6 | 7443 |
Tubb3 | 7249 |
Tubb4a | 7218 |
Tubb2b | 6485 |
Mapt | 5513 |
Tuba4a | 5172 |
Prkag1 | 4832 |
Tuba8 | 4754 |
Tuba1c | 2959 |
Prkab1 | 1684 |
Prkag2 | 149 |
Camkk2 | -3989 |
Prkab2 | -4187 |
Prkaa1 | -5555 |
Prkaa2 | -7286 |
Calm1 | -7912 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
111 | |
---|---|
set | CAMK IV MEDIATED PHOSPHORYLATION OF CREB |
setSize | 10 |
pANOVA | 0.0644 |
s.dist | -0.338 |
p.adjustANOVA | 0.279 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Calm1 | -7912 |
Camk2a | -7606 |
Camk2d | -7201 |
Camk4 | -5897 |
Creb1 | -4279 |
Camkk2 | -3989 |
Kpna2 | -651 |
Camk2b | 1442 |
Camkk1 | 1722 |
Camk2g | 4876 |
GeneID | Gene Rank |
---|---|
Calm1 | -7912 |
Camk2a | -7606 |
Camk2d | -7201 |
Camk4 | -5897 |
Creb1 | -4279 |
Camkk2 | -3989 |
Kpna2 | -651 |
Camk2b | 1442 |
Camkk1 | 1722 |
Camk2g | 4876 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS
236 | |
---|---|
set | DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS |
setSize | 18 |
pANOVA | 0.0141 |
s.dist | 0.334 |
p.adjustANOVA | 0.107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pgm1 | 8304 |
Neu1 | 8207 |
Galk1 | 8079 |
Dpm3 | 7165 |
Gale | 6210 |
Dhdds | 5100 |
Mpi | 4444 |
Dolk | 3470 |
Srd5a3 | 2958 |
Glb1 | 2455 |
Gne | 2098 |
Ctsa | 2031 |
Galt | 770 |
Dpm2 | -80 |
Pmm2 | -482 |
Nus1 | -3130 |
Gfpt1 | -3689 |
Dpm1 | -3814 |
GeneID | Gene Rank |
---|---|
Pgm1 | 8304 |
Neu1 | 8207 |
Galk1 | 8079 |
Dpm3 | 7165 |
Gale | 6210 |
Dhdds | 5100 |
Mpi | 4444 |
Dolk | 3470 |
Srd5a3 | 2958 |
Glb1 | 2455 |
Gne | 2098 |
Ctsa | 2031 |
Galt | 770 |
Dpm2 | -80 |
Pmm2 | -482 |
Nus1 | -3130 |
Gfpt1 | -3689 |
Dpm1 | -3814 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
452 | |
---|---|
set | INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE |
setSize | 22 |
pANOVA | 0.00693 |
s.dist | 0.333 |
p.adjustANOVA | 0.0659 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sgta | 7678 |
Get3 | 7456 |
Stx1a | 7298 |
Get1 | 7198 |
Stx5a | 6889 |
Get4 | 6825 |
Emd | 6126 |
Bag6 | 5819 |
Sec61g | 5347 |
Sec61b | 5240 |
Hmox1 | 3876 |
App | 2245 |
Ubl4a | 1734 |
Cyb5a | 415 |
Ube2j2 | 105 |
Prnp | -110 |
Otof | -339 |
Caml | -880 |
Aldh3a2 | -1617 |
Vapa | -2474 |
GeneID | Gene Rank |
---|---|
Sgta | 7678 |
Get3 | 7456 |
Stx1a | 7298 |
Get1 | 7198 |
Stx5a | 6889 |
Get4 | 6825 |
Emd | 6126 |
Bag6 | 5819 |
Sec61g | 5347 |
Sec61b | 5240 |
Hmox1 | 3876 |
App | 2245 |
Ubl4a | 1734 |
Cyb5a | 415 |
Ube2j2 | 105 |
Prnp | -110 |
Otof | -339 |
Caml | -880 |
Aldh3a2 | -1617 |
Vapa | -2474 |
Vamp2 | -3525 |
Serp1 | -4396 |
DISEASES OF CARBOHYDRATE METABOLISM
239 | |
---|---|
set | DISEASES OF CARBOHYDRATE METABOLISM |
setSize | 28 |
pANOVA | 0.00248 |
s.dist | 0.33 |
p.adjustANOVA | 0.0322 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sgsh | 8093 |
Gaa | 7838 |
Taldo1 | 7523 |
Ubb | 7291 |
G6pc3 | 6828 |
Khk | 6701 |
Nhlrc1 | 5452 |
Galns | 5079 |
Uba52 | 4626 |
Hyal1 | 4498 |
Gys1 | 4196 |
Gbe1 | 4072 |
Gusb | 4020 |
Ppp1r3c | 3895 |
Rpia | 3041 |
Ubc | 2638 |
Rps27a | 2557 |
Glb1 | 2455 |
Gns | 2361 |
Aldob | 1986 |
GeneID | Gene Rank |
---|---|
Sgsh | 8093 |
Gaa | 7838 |
Taldo1 | 7523 |
Ubb | 7291 |
G6pc3 | 6828 |
Khk | 6701 |
Nhlrc1 | 5452 |
Galns | 5079 |
Uba52 | 4626 |
Hyal1 | 4498 |
Gys1 | 4196 |
Gbe1 | 4072 |
Gusb | 4020 |
Ppp1r3c | 3895 |
Rpia | 3041 |
Ubc | 2638 |
Rps27a | 2557 |
Glb1 | 2455 |
Gns | 2361 |
Aldob | 1986 |
Dcxr | 670 |
Idua | 607 |
Naglu | -1234 |
Hgsnat | -1380 |
Arsb | -1426 |
Gyg | -1664 |
Epm2a | -6696 |
Ids | -7067 |
KERATAN SULFATE DEGRADATION
505 | |
---|---|
set | KERATAN SULFATE DEGRADATION |
setSize | 12 |
pANOVA | 0.0518 |
s.dist | 0.324 |
p.adjustANOVA | 0.239 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hexa | 7239 |
Prelp | 6607 |
Fmod | 6014 |
Lum | 5928 |
Galns | 5079 |
Glb1l | 3632 |
Omd | 2868 |
Glb1 | 2455 |
Gns | 2361 |
Ogn | -441 |
Acan | -3734 |
Hexb | -5622 |
GeneID | Gene Rank |
---|---|
Hexa | 7239 |
Prelp | 6607 |
Fmod | 6014 |
Lum | 5928 |
Galns | 5079 |
Glb1l | 3632 |
Omd | 2868 |
Glb1 | 2455 |
Gns | 2361 |
Ogn | -441 |
Acan | -3734 |
Hexb | -5622 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
85 | |
---|---|
set | AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA |
setSize | 53 |
pANOVA | 4.72e-05 |
s.dist | 0.323 |
p.adjustANOVA | 0.00199 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Hspb1 | 7813 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Eif4g1 | 5089 |
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Hspb1 | 7813 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Eif4g1 | 5089 |
Psmb10 | 4883 |
Psmc2 | 4874 |
Uba52 | 4626 |
Psmb7 | 4582 |
Psmb1 | 4506 |
Psmd2 | 4249 |
Psma2 | 4186 |
Psma7 | 4046 |
Hspa8 | 3751 |
Psmb3 | 3606 |
Psmd9 | 3385 |
Ubc | 2638 |
Rps27a | 2557 |
Psma6 | 2335 |
Psmd6 | 2277 |
Psmd5 | 1752 |
Psmd1 | 1242 |
Psmd14 | 138 |
Psme3 | -87 |
Psma4 | -131 |
Hspa1a | -835 |
Psma1 | -846 |
Psmf1 | -1102 |
Psma3 | -1208 |
Psmd11 | -2344 |
Psmc1 | -2685 |
Psmd12 | -4537 |
Psmc6 | -5059 |
Psme4 | -5592 |
Psmb8 | -6856 |
Pabpc1 | -6888 |
Hnrnpd | -7269 |
Psmb9 | -7446 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
190 | |
---|---|
set | CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES |
setSize | 46 |
pANOVA | 0.00016 |
s.dist | 0.322 |
p.adjustANOVA | 0.00473 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Mrc2 | 7063 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Psmb10 | 4883 |
Psmc2 | 4874 |
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Mrc2 | 7063 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Psmb10 | 4883 |
Psmc2 | 4874 |
Psmb7 | 4582 |
Psmb1 | 4506 |
Psmd2 | 4249 |
Psma2 | 4186 |
Psma7 | 4046 |
Psmb3 | 3606 |
Psmd9 | 3385 |
Psma6 | 2335 |
Psmd6 | 2277 |
Psmd5 | 1752 |
Psmd1 | 1242 |
Psmd14 | 138 |
Psme3 | -87 |
Psma4 | -131 |
Psma1 | -846 |
Psmf1 | -1102 |
Psma3 | -1208 |
Psmd11 | -2344 |
Psmc1 | -2685 |
Mrc1 | -3329 |
Fcgr1 | -4226 |
Psmd12 | -4537 |
Psmc6 | -5059 |
Psme4 | -5592 |
Psmb8 | -6856 |
Psmb9 | -7446 |
KERATAN SULFATE BIOSYNTHESIS
504 | |
---|---|
set | KERATAN SULFATE BIOSYNTHESIS |
setSize | 24 |
pANOVA | 0.0064 |
s.dist | 0.322 |
p.adjustANOVA | 0.0639 |
Top enriched genes
GeneID | Gene Rank |
---|---|
B4galt2 | 8171 |
St3gal4 | 8159 |
B4galt4 | 7662 |
B4galt3 | 7116 |
St3gal2 | 6982 |
Prelp | 6607 |
Chst1 | 6358 |
Chst5 | 6328 |
Fmod | 6014 |
Lum | 5928 |
St3gal3 | 3818 |
B3gnt4 | 3752 |
B4gat1 | 3393 |
B4galt5 | 2885 |
Omd | 2868 |
Chst2 | 1885 |
B3gnt7 | 262 |
B3gnt2 | -422 |
Ogn | -441 |
St3gal1 | -1813 |
GeneID | Gene Rank |
---|---|
B4galt2 | 8171 |
St3gal4 | 8159 |
B4galt4 | 7662 |
B4galt3 | 7116 |
St3gal2 | 6982 |
Prelp | 6607 |
Chst1 | 6358 |
Chst5 | 6328 |
Fmod | 6014 |
Lum | 5928 |
St3gal3 | 3818 |
B3gnt4 | 3752 |
B4gat1 | 3393 |
B4galt5 | 2885 |
Omd | 2868 |
Chst2 | 1885 |
B3gnt7 | 262 |
B3gnt2 | -422 |
Ogn | -441 |
St3gal1 | -1813 |
B4galt6 | -3696 |
Acan | -3734 |
B4galt1 | -6116 |
St3gal6 | -7782 |
SIGNALING BY FGFR3 FUSIONS IN CANCER
955 | |
---|---|
set | SIGNALING BY FGFR3 FUSIONS IN CANCER |
setSize | 10 |
pANOVA | 0.0793 |
s.dist | -0.32 |
p.adjustANOVA | 0.315 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Frs2 | -7121 |
Kras | -6899 |
Pik3r1 | -6574 |
Nras | -6568 |
Gab1 | -6536 |
Sos1 | -4005 |
Grb2 | 2781 |
Hras | 6195 |
Fgfr3 | 8471 |
GeneID | Gene Rank |
---|---|
Pik3ca | -7766 |
Frs2 | -7121 |
Kras | -6899 |
Pik3r1 | -6574 |
Nras | -6568 |
Gab1 | -6536 |
Sos1 | -4005 |
Grb2 | 2781 |
Hras | 6195 |
Fgfr3 | 8471 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
819 | |
---|---|
set | REGULATION OF RUNX3 EXPRESSION AND ACTIVITY |
setSize | 53 |
pANOVA | 5.77e-05 |
s.dist | 0.319 |
p.adjustANOVA | 0.00221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Psmb10 | 4883 |
Psmc2 | 4874 |
GeneID | Gene Rank |
---|---|
Psmd7 | 8169 |
Psmc4 | 8152 |
Psmd3 | 8001 |
Psmb5 | 7501 |
Psme1 | 7422 |
Psmd13 | 7345 |
Ubb | 7291 |
Psmb4 | 6979 |
Sem1 | 6865 |
Psmc3 | 6769 |
Psmd4 | 6676 |
Psmb6 | 6408 |
Psmb2 | 6259 |
Psmc5 | 6152 |
Psmd10 | 5869 |
Psma5 | 5777 |
Psme2 | 5538 |
Psmd8 | 5385 |
Psmb10 | 4883 |
Psmc2 | 4874 |
Uba52 | 4626 |
Psmb7 | 4582 |
Psmb1 | 4506 |
Psmd2 | 4249 |
Psma2 | 4186 |
Src | 4100 |
Psma7 | 4046 |
Psmb3 | 3606 |
Psmd9 | 3385 |
Tgfb1 | 2824 |
Ubc | 2638 |
Rps27a | 2557 |
Psma6 | 2335 |
Psmd6 | 2277 |
Psmd5 | 1752 |
Psmd1 | 1242 |
Psmd14 | 138 |
Mdm2 | 120 |
Psme3 | -87 |
Psma4 | -131 |
Psma1 | -846 |
Psmf1 | -1102 |
Psma3 | -1208 |
Smurf1 | -1561 |
Ep300 | -2008 |
Psmd11 | -2344 |
Psmc1 | -2685 |
Cbfb | -3645 |
Psmd12 | -4537 |
Psmc6 | -5059 |
Smurf2 | -5447 |
Psmb8 | -6856 |
Psmb9 | -7446 |
RA BIOSYNTHESIS PATHWAY
766 | |
---|---|
set | RA BIOSYNTHESIS PATHWAY |
setSize | 12 |
pANOVA | 0.0555 |
s.dist | 0.319 |
p.adjustANOVA | 0.251 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Aldh1a1 | 8243 |
Crabp1 | 7111 |
Rdh5 | 7035 |
Dhrs4 | 6318 |
Rdh14 | 2712 |
Rdh11 | 2135 |
Rdh10 | 1552 |
Aldh1a3 | 1356 |
Rdh13 | 1084 |
Dhrs3 | 973 |
Aldh1a2 | -1666 |
Cyp26b1 | -4966 |
GeneID | Gene Rank |
---|---|
Aldh1a1 | 8243 |
Crabp1 | 7111 |
Rdh5 | 7035 |
Dhrs4 | 6318 |
Rdh14 | 2712 |
Rdh11 | 2135 |
Rdh10 | 1552 |
Aldh1a3 | 1356 |
Rdh13 | 1084 |
Dhrs3 | 973 |
Aldh1a2 | -1666 |
Cyp26b1 | -4966 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.3 (2022-03-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] gtools_3.9.2 echarts4r_0.4.3
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7 kableExtra_1.3.4
## [9] topconfects_1.8.0 limma_3.48.3
## [11] eulerr_6.1.1 mitch_1.4.1
## [13] MASS_7.3-55 fgsea_1.18.0
## [15] gplots_3.1.1 DESeq2_1.32.0
## [17] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [19] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [21] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [23] IRanges_2.26.0 S4Vectors_0.30.2
## [25] BiocGenerics_0.38.0 reshape2_1.4.4
## [27] forcats_0.5.1 stringr_1.4.0
## [29] dplyr_1.0.8 purrr_0.3.4
## [31] readr_2.1.2 tidyr_1.2.0
## [33] tibble_3.1.6 ggplot2_3.3.5
## [35] tidyverse_1.3.1 zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] readxl_1.3.1 backports_1.4.1 fastmatch_1.1-3
## [4] systemfonts_1.0.3 plyr_1.8.6 polylabelr_0.2.0
## [7] splines_4.1.3 BiocParallel_1.26.2 digest_0.6.29
## [10] htmltools_0.5.2 fansi_1.0.2 magrittr_2.0.2
## [13] memoise_2.0.1 tzdb_0.2.0 Biostrings_2.60.2
## [16] annotate_1.70.0 modelr_0.1.8 svglite_2.1.0
## [19] prettyunits_1.1.1 colorspace_2.0-2 blob_1.2.2
## [22] rvest_1.0.2 haven_2.4.3 xfun_0.29
## [25] crayon_1.4.2 RCurl_1.98-1.6 jsonlite_1.7.3
## [28] genefilter_1.74.1 survival_3.2-13 glue_1.6.1
## [31] polyclip_1.10-0 gtable_0.3.0 zlibbioc_1.38.0
## [34] XVector_0.32.0 webshot_0.5.2 DelayedArray_0.18.0
## [37] scales_1.1.1 DBI_1.1.2 Rcpp_1.0.8
## [40] progress_1.2.2 viridisLite_0.4.0 xtable_1.8-4
## [43] bit_4.0.4 htmlwidgets_1.5.4 httr_1.4.2
## [46] RColorBrewer_1.1-2 ellipsis_0.3.2 farver_2.1.0
## [49] pkgconfig_2.0.3 reshape_0.8.8 XML_3.99-0.8
## [52] sass_0.4.0 dbplyr_2.1.1 locfit_1.5-9.4
## [55] utf8_1.2.2 labeling_0.4.2 tidyselect_1.1.1
## [58] rlang_1.0.1 later_1.3.0 AnnotationDbi_1.54.1
## [61] munsell_0.5.0 cellranger_1.1.0 tools_4.1.3
## [64] cachem_1.0.6 cli_3.1.1 generics_0.1.2
## [67] RSQLite_2.2.9 broom_0.7.12 evaluate_0.14
## [70] fastmap_1.1.0 yaml_2.2.2 knitr_1.37
## [73] bit64_4.0.5 fs_1.5.2 caTools_1.18.2
## [76] KEGGREST_1.32.0 mime_0.12 xml2_1.3.3
## [79] compiler_4.1.3 rstudioapi_0.13 png_0.1-7
## [82] reprex_2.0.1 geneplotter_1.70.0 bslib_0.3.1
## [85] stringi_1.7.6 highr_0.9 desc_1.4.0
## [88] lattice_0.20-45 Matrix_1.4-0 vctrs_0.3.8
## [91] pillar_1.7.0 lifecycle_1.0.1 jquerylib_0.1.4
## [94] data.table_1.14.2 bitops_1.0-7 httpuv_1.6.5
## [97] R6_2.5.1 promises_1.2.0.1 KernSmooth_2.23-20
## [100] gridExtra_2.3 assertthat_0.2.1 rprojroot_2.0.2
## [103] withr_2.4.3 GenomeInfoDbData_1.2.6 hms_1.1.1
## [106] grid_4.1.3 rmarkdown_2.11 shiny_1.7.1
## [109] lubridate_1.8.0
END of report